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ABSTRACT
This study dem onstrates the use of submerged limb culture in teratologic 
testing. Pregnant mice were trea ted  on day 11 of gestation (E ll,  plug date  = 
EO) with 10, 20 or 40 mg of 5-fluorouracil (FU) per kg body weight. On E17, 
trea ted  and untreated fetuses were examined for gross malformations and were 
fixed in 95% ethanol. Reduction of limb size and digital defects, including 
ectrodactyly  (ED), syndactyly (SD), microdactyly and polydactyly were 
dose-dependent. Higher doses resulted in apody, c le ft palates, ta il defects, 
increased embryotoxicity, decreased fe ta l wet weight, micrognathia, 
exencephaly, omphalocoele and auricle/eye defects. In parallel studies, 
pregnant mice were trea ted  on the morning of E l l  and embryos were removed 
e ither 7h (E ll)  or 24h (E l2) la te r for submerged limb culture. Limbs cultured 
for three days were fixed, stained with Alcian blue and mounted on slides. 
Mounted limbs were examined quantitatively for FU-Induced changes in bone 
area and shape using optical image analysis. Changes in limb area showed a 
dose-response relationship while treatm ent had little  e ffec t on the shape of 
individual bones. This indicates the relatively unspecific nature of FU-induced 
embryotoxicity. E l l  studies revealed a  dose dependent response of ED, SD and 
fusion of the m etacarpals/m etatarsals (MC/MT) to the proximal phalanges. Paw 
skeleton was completely locking in some limbs trea ted  with 40 mg/kg FU. E l2 
cultures exhibited similar but less severe results. Unlike E l l  cultures, middle 
phalanges were present but decreased in number as dosage increased. Limbs 
from embryos of un treated  females were cultured (E ll)  in the presence of
0.002, 0.02, 0.2 or 2.0 mg FU/ml culture medium. The percentage of limbs void 
of paw cartilage or with decreased numbers of MC/MT was dose-dependent. 
Phalanges were present only in the lower treatm ent groups. A- dose-dependent 
decrease in the deleterious effects of 0.02 mg FU/ml was observed when 0.2 or
0.02 mg thymine/ml was added to  the cultures, but 0.002 mg thymine/ml 
enhanced the FU e ffec ts . In both culture and non-culture studies, hindlimbs 
(HL) were more affected  than forelimbs (FL) and distal regions were more 
a ffec ted  than proximal ones. These results re flec t the temporal sequence of 
limb development. Defects observed in culture studies were similar but more 
severe than in the In vivo study. In addition to the morphometric analyses, 
biochemical param eters of growth (to tal DNA content) and differentiation (total 
protein content) were examined a t  0, 36 and 72h of culture in untreated  and 
trea ted  (in vivo or in vitro) limbs. Both DNA and protein of FU trea ted  limbs 
were decreased compared to  untreated  controls. FL dem onstrated g rea ter 
capacity for regulation o f losses In protein content, HL for DNA content. 
Submerged limb culture provides a  useful model for the examination of 
xenobiotic effects  on limb development and allows some comparative evaluation 
among in vivo, in vivo/in vitro and in vitro studies.
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CHAPTER 1 
INTRODUCTION
The sciences of teratology/developm ental toxicology are based on 
in terests th a t may be summarized in two general questions. Does a given 
agent exert an influence on the developing organism? If so, how is th a t 
e ffec t managed? The approach to the first question involves a 
generalized methodology. An established protocol is usually followed. 
Varying treatm ent dosages are administered to pregnant females a t 
specific stages of fe ta l organogenesis and near-term  offspring are 
examined for gross malformation or lethality . The applicability of these 
animal tests to the ultim ate concern, human risk assessment, will perhaps 
uiways be questioned. To minimize those doubts, one is forced to 
concentrate on the second question, the mechanism of action. This 
concern evolved somewhat la te r than the first. It is obvious th a t a 
reasonable scientific approach to the question must be considerate of the 
agent being examined. While a  number of exogenous (or endogenous) 
influences may result in the same developmental abnormality, the 
mechanism of action involved is specific to the treatm ent: (1) the agent 
involved, (2) the stage of administration, (3) dosage used and (4) 
genomic background of the animal model.
Increasingly, scientists are asked to consider if the classical in vivo 
testing model is in pace with the  current in terests and needs of its 
founding science. Can these methods be used to  provide adequate 
teratologic testing? Are these methods amenable to consideration of 
d iscrete mechanisms of action? Recognizing the obvious response does
not require one to  contest the validity or desirability of in vivo animal 
testing  in the proper setting. It does, however, require recognition o f the 
inadequacies of standard protocols and development of new protocols to 
fill these gaps.
One such new protocol is the use of organ culture. In vitro  
techniques such as organ culture are  demonstrating enormous potential in 
many fields of science. While limb bud culture is exceptionally valuable 
for the study of developmental questions and for elucidation of drug 
actions, its use as a reliable teratologic screening system awaits more 
widespread testing (67, 146). The validity of such use of in vitro systems 
Is dependent upon the demonstration tha t e ffec ts  produced in utero are 
duplicated in vitro.
The study reported here dem onstrates the use of embryonic mouse 
limb bud culture in teratologic testing using a known teratogen, 
5-fluorouracil, Several well-defined, quantitative endpoints are selected 
for evaluation: the incidence of missing (ectrodactylous) or fused
(syndactylous) paw elements; area and shape of individual bone anlagen; 
to ta l limb, bone and soft tissue areas; ratios o f long bones/paw and soft 
tissue/bone; to ta l DNA and protein content of trea ted  vs. non-treated 
limbs. Four separate  culture experiments were performed: (1) treatm ent 
jn  u tero  followed by culture 24h la te r (El 2 in vivo/in vitro), (2) 
treatm ent in u tero  followed by culture 7h la te r (E ll  in vivo/in vitro), (3) 
culture of previously untreated limb buds in the presence of FU (E ll  In 
vitro) and (4) culture of previously un treated  limb buds in the presence 
of a moderate dose of FU and varying doses of thymine (E l l  in v itro , 
Thymine rescue). These in vitro results a re  compared, when reasonable, 
to results obtained in a classical, whole animal in vivo study.
The major objectives of the experiments were to: (1) define the 
teratologic nature of FU in ICR mice autopsied on E17 following in utero 
exposure on E l l ,  (2) compare the e ffec ts  of FU on limb development as 
defined in vivo to  studies in vitro, (3) determine whether FU 
administered in vitro to  un treated  limbs is capable of altering  normal limb 
morphogenesis, (4) examine whether co-administration of thymine is 
capable of modulating e ffec ts  of FU as defined in the in vitro studies, (5) 
monitor biochemical param eters of growth and development (to tal DNA 
and protein content) in cultured limbs trea ted  in vivo or in vitro, (6) 
examine the nature of FU-induced limb defects using information obtained 
from quantitative image analysis with regard to the ta rg e t tissue(s) 
a ffected , and (7) identify the normal processes of limb development as 
they re la te  to FU teratogenicity .
Historical Perspective
"There are reckoned up many causes of monsters; the first 
whereof is the glory of God, th a t his immense power may be 
manifested to  those which are ignorant of it. . . Another cause is, 
th a t God may punish men's wickedness, or show signs of punishment 
a t  hand. . . The third cause is, an abundance of seed and 
overflowing m atter. . If, on the contrary, the seed be anything 
deficient in quantity, some or more members will be wanting, or 
more short and decrepite . . . The ancients have marked other 
causes of the generation of monsters. . . the force of imagination 
hath much power over the infant. , . Monsters a re  bred and caused 
by the straightnesse of the womb. . . by the ill placing of the 
mother in sitting , lying downe or any other site  of the body in the 
time of her being with child. . . By the injury of hereditary 
diseases, infants grow monstrous, for crooke-baokt produce 
crooke-backt, lame produce lame, flat-nosed their like, . . Monsters 
a re  also occasioned by the c ra ft and subtlety of the Devil."
The words of 16th century surgeon Ambroise Pare* (94) well 
illustra te  the mystique with which the Renaissance physician 
contem plated malformations. As in terest in normal development 
progressed, many scien tists began to recognize tha t fe ta l abnormalities 
were not random Rearrangem ents of tissue but resulted from the 
persistence of normal embryonic developmental stages (49, 82, 137, 148). 
A g rea t deal of lite ra tu re  was amassed in descriptive teratology as 
malformations were named and catalogued (109, 127).
Early in this century, experim ental teratology emerged from the 
work of many investigators who dem onstrated th a t deform ities could be 
produced by subjecting embryos, largely amphibian or piscine, to a  host of 
environmental factors (19). Further, the deformities produced in the 
laboratory resembled naturally occurring abnormalities. The mammalian 
embryo, however, was generally considered immune to external 
manipulation due to its unique haven within the protective environment of 
specialized membranes, the placenta. Fetal aberration in these animals 
was viewed as secondary to  uterine disease, the  primary lesion of 
environmental agents (78). However, many laboratories continued to 
report considerable numbers of aberrant fetuses contained in healthy 
u terine environments (19, 96). Thus, a  new hypothesis emerged which 
suggested th a t anomalie/morbidity was the result of specific genetic 
defects found within the fetus (5, 45, 50, 71, 123). One mildly 
disconcerting observation was tha t the presumed genetic defects observed 
in mammalian embryos often  resembled those defects experimentally 
produced in lower vertebrates. The discomfort of these observations was 
largely allayed by the proposal of Charles R. Stockard (122) th a t ". . .
The same structu ra l abnormality may be induced in the embryos of various 
species by a  g rea t number of d ifferen t experim ental tre a t men ts.". Thus 
any disruption, environmental o r gene mediated, of an acute  
developmental event could result in similar deform ities.
Perhaps since genetics was the emerging science of the time, 
theories of inherent cause for dysmorphogenesls dominated thought for 
several years. Subsequently, genetic facto rs have been estim ated to 
cause not more than 20% of human birth d e fec ts  (17, 41, 87). It was 
nearly th ree  decades a f te r  researchers reported the experimental 
production of deform ities in non-mammalian embryos tha t environmental 
causes were d irectly  implicated in abnormal development of mammalian 
embryos. Many of these early  observations regarded the role of 
hypovitaminosis on development (46, 139, 140, 143). Also, the multiple 
defic its noted in children exposed in u tero  to rubella fu rther demanded 
our understanding th a t perturbation of the m aternal environment could 
have deleterious consequences for the fetus (29, 44).
As it became more obvious th a t mammalian embryos were not 
isolated from their environment, various guidelines for the testing of 
chemical agents emerged. Initially, the primary objective seemed to  be 
the elucidation of e ffec ts  on reproduction and fe rtility  (3). In the wake 
of the thalidomide d isaster in the early  1960's (72, 81), the Food and Drug 
Administration established the regulatory "Guidelines for Reproductive 
Studies for Safety Evaluation of Drugs for Human Use" (38). The design 
of these te sts  is to administer varying doses o f an agent to impregnated 
females during specific stages of organogenesis. Shortly before 
parturition, offspring are removed and examined for embryotoxicity,
6growth retardation , external, visceral and skeletal malformations. 
Provided tha t the number of agents to be tested  remained relatively 
small, this in vivo protocol would prove an admirable, though not 
infallible, teratologic te s t system, especially if prim ate animal models 
were used. However, there  is such an enormous spectrum of chemical 
en tities to which we are exposed, intentionally or inadvertantly, th a t such 
a testing scheme is unrealistic. Currently, the Chemical A bstract Service 
of the American Chemical Society reports a listing of over seven million 
chemicals and the number grows by about 7000 per week (Chemical 
A bstract Service, Columbus, Ohio; personal communication, August 1985).
Testing In Vitro
If in vivo protocols prove im practical as first-line testing, science 
is obliged to consider reasonable alternatives. Many researchers have 
recognized the need to  develop in v itro  screening models (27, 57, 62, 88, 
107, 112,). The most suitable system would dem onstrate several v ital 
fea tu res (51, 62, 133, 146):
1. The animal model used should be available in large numbers and 
be relatively inexpensive to maintain. Mammalian subjects are 
preferred  to  lower vertebrates.
2. It is essential th a t the system display some aspects of 
progressive development and is ideal if it involves many 
developmental processes (e.g. cellular proliferation, d iffer­
entiation, communication, induction, migration, programmed cell 
death). Thus, a system utilizing a  heterogenous mass proves 
more useful than a homogenous cell or tissue culture.
3. The te s t system should dem onstrate relevance to current 
theories and concepts of the mechanisms of teratogenesis (e.g. 
cell death, blockage of synthesis or function of macromolecules, 
membrane effec ts , in terference with in tercellular communication, 
energy cycle disruptions; 98, 99, 114, 152).
4. To be of prac tica l value, the te s t protocol must be simple and 
the results obtained must be reproducible and easily analyzed.
5. The te s t system should dem onstrate responsiveness to many 
different types of agents.
6. In v itro  results should correlate  to whole animal studies.
Many advantages ore posed by the use of in vitro  testing.
Accessibility of ta rg e t tissue to d irect observation and manipulation, 
control of dosage and exposure to the te s t agent, avoidance of 
m aternal/placental metabolism of the te s t agent, and reproducibility of 
results are a few (64). A review of current In vitro methods is provided 
by Wilson (146) and includes the use of microorganisms, cell, tissue, organ 
and whole embryo cultures. Of these systems, whole embryo and organ 
culture appear to  most satisfactorily  fulfill the desired c rite ria  listed 
above.
Successful culture of postimplantation embryos has been rigorously 
pursued (91) but several problems prevent its  reliable use as a 
teratological screen. Primarily, whole embryos in culture display only 
short periods of viability or development (36). The use of homologous or 
heterologous sera in the culture medium allows improved longevity but 
also complicates the evaluation of drug action.
8B etter success is achieved with organs in culture including kidney 
(108), pancreas (80), ovaries (32), palate  (92), tooth (129) and limbs 
(64, 65). The embryonic limb is especially suited for use in an in vitro  
screening system. Its developmental history encompasses many of the 
processes crucial to normal embryogenesls. Therefore, results obtained 
from examination of xenobiotic e ffec ts  on limb development could be 
broadly applicable to other organ systems (27, 62).
Limb Development
Limb growth is first apparent as an accumulation of mesoderm along 
the embryonic flank (153). As regional cell proliferation continues, the  
limb bud first appears as a mesodermal core covered with ectoderm. 
Continued growth is dependent upon mesodermal production of specific 
chemical inducers, morphogens, which stim ulate elaboration o f the distal 
ectoderm al covering to form the apical ectoderm al ridge (AER). Further, 
the integrity of the AER is dependent on maintenance factors produced 
by the mesoderm (104). In turn, the AER influences mesodermal growth 
proximo-distally; removal of the AER during development results in loss 
of distal structu res (101, 119, 151). During paw formation, the AER is 
reduced to 5 d istinct foci which continue to  in te rac t with underlying 
mesoderm to give rise to  the digits. The ectoderm and subjacent 
mesoderm between these inductive islands undergo program m ed cell 
death" (102) to  form the interdigital spaces. Finally, when the bone 
anlagen of the paw are established, the AER degenerates completely (84,
153). Though the concept of AER-governed mesodermal outgrowth is 
generally accepted, it  does not remain unequivocal. Amprino (2) considers 
the AER to be a passive ectoderm al shell which is kept filled with 
autoregulated mesoderm.
In addition to regulated proximo-distal growth, a second, 
perpendicular axis of polarization is being considered. A region within 
the post-axial mesoderm capable of interacting with the AER and of 
specifying limb growth in the anteroposterior plane has been 
conceptualized (6). The nature of this zone of polarizing activ ity  (ZPA) 
is not understood but experim entation suggests th a t a  diffuseable 
chemical morphogen is involved (12, 126, 76). Further, it  appears tha t 
the signal-receptor complex is highly conserved in evolutionary terms as 
indicated by remarkable interspecies cross-reactiv ity  (35, 75, 132).
The proposed activ ity  of the ZPA was derived from various grafting 
procedures (77, 103, 125) but evidence of activ ity  in situ  is less 
convincing. Excision of the ZPA during c ritica l stages of limb 
development does not result in specific, remarkable trauma (34, 74) 
which has led some investigators to conclude th a t the ZPA does not have 
a polarizing role in normal limb development (105, 106). However, more 
recen t attem pts have dem onstrated th a t thorough amputation of the ZPA 
results in rapid regression of the AER and death of distal mesenchyme 
(52). This and other evidence supports the contention tha t the ZPA does 
play a  controlling role in normal and manipulated limb growth (55). Most 
attem pts to explain the pattern  of b lastem ata formation in the limb rely 
on the assumption th a t the ZPA is the source of a  diffuseable signal 
substance (124, 131, 141).
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A crucial fea tu re  of limb development is the morphological 
differentiation of the mesenchyme. Initially, these cells present as a 
homogenous mass but they eventually proceed through distinct lineages to 
give rise to tissue-specific cell populations: chondroblasts, fibroblasts
and myoblasts. Although originally regarded as to tipotential, i.e. capable 
of forming any one of the three major mesodermal derivatives (154), 
recent evidence implies tha t early limb mesenchyme is comprised of two 
d istinct populations (93). One, of somatopleural origin, gives rise to 
connective tissue elements while the second, derived from somitic 
mesoderm, forms muscle (16, 25). The factors in itiating and regulating 
cellular determination are not defined but may involve physical 
param eters such os oxygen tension, m etabolite distribution, cues provided 
by the extracellu lar m atation, programmed events or cell density (14, 54, 
117).
With regard to  limb bud culture, the formation of the cartilaginous 
models of fu ture bone is of particular in terest. Though the regulatory 
mechanisms governing cartilage formation have not been elucidated, 
several events have been described. One of the earliest events is the 
withdrawal of presumptive chondroblasts from the proliferative pool. 
Cells within central limb regions dem onstrate a 50% decline in labeling 
index compared to peripheral (myogenic) areas (63). Shortly thereafter, 
these central core cells condense forming densely populated cell islands in 
con trast to the loose mesh of embryonic mesoderm peripherally (28, 130). 
The labeling index continues to fall and is only about 7% of the original 
value when the celts begin to express functional maturation (63). The 
elaboration of matrix m aterial, type II collagen and sulfated
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proteoglycans, signifies the m aturational s ta te  of the chondroblasts and 
may aid in stabilizing the cells in their d ifferen tia ted  s ta te  (110).
The cartilaginous blastema of the limb do not form simultaneously 
but ra ther develop along a  temporal axis proceeding proximodlstally and 
postero-anteriorly. The sequence of condensations in the mouse is 
scapula, humerus, ulna, digits IV, V, radius, digits III, II, 1 and carpals 
(39). However, once formed, the condensations acquire a  s ta te  of 
autonomy expressed in d ifferential growth ra tes  (31, 52). Thus, although 
the fibular island appears before the tibial one, the la tte r  rapidly 
overcomes the fibula in growth and in the incorporation of heavy su lfa te  
in vivo and in vitro (Hicks unpublished; cited in 52).
Another expression of autonomy is the d ifferen tia l regulation 
displayed by the growing condensations. Regulation is the ability to 
compensate for additions/deletions of tissue such th a t a  normal s truc tu re  
ultim ately forms. As demonstrated in early chick wing buds, the limb was 
capable of regulated growth when the position or proportion of mesoderm 
was altered  (the AER and subridge mesenchyme were le f t in tact; 149). 
However, regulatory capabilities of individual limb blastema a re  not 
similar. Hampe (47) dem onstrated th a t the fibula was more sensitive to 
changes in tissue mass than was the tibia.
Thus, limb development involves an array of embryogenic phenomena 
which make this organ highly suitable for use in in v itro  testing  of 
xenobiotics; cell migration, proliferation, selective withdrawal from 
proliferative pools, induction, epithelial-mesenchymal interactions, 
aggregation, regulation, in tercellu lar communication, progression through 
cell lineage, expression of d ifferen tia ted  stage and genetically regulated
12
cell death. Therefore, this system should be capable of responding to a 
broad spectrum of exogenous agents. The sciences of teratology/develop­
mental toxicology are not in terested  solely in whether or not a  test agent 
will dem onstrate deleterious e ffec ts . Also of great importance is 
understanding the mechanism of drug action. The temporal orchestration 
of developmental events in the limb allow the user to consider the effects 
of a  test agent on one of several phenomena occurring simultaneously and 
may assist in identifying mode of action.
Limb Culture
An in vitro  screening system would not be prac tica l if it were not 
easily performed and if the data  could not be easily analyzed. Several 
technical modifications have improved the reliability of the limb culture 
system since its initial development and use. Originally, limbs were 
grown on moistened f ilte r  paper kept a t  the air-liquid interphase of a 
serum-supplemented commercial culture medium (4). In this system, oxygen 
delivery to  the lower portion of the explant was necessarily different 
from th a t portion exposed to  the gaseous phase. Conversely, the upper 
regions of the limb were not directly  exposed to the culture medium, 
hence to nutrients and experimental additives. Fainstat (33) reported 
th a t surface culture of ra t  ovaries resulted in variable tissue viability. 
The number of mitotic figures was g rea ter for regions closest to  the 
medium while exposed surfaces revealed necrotic foci. The la tte r  regions 
were also less capable of responding to steroid additives. When ovaries 
were grown in submerged culture, however, the tissue appeared uniformity 
viable, m itotic figures were more evenly distributed and steroidal 
responsiveness was less localized.
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Using the surface culture method, Lessmollmann e t al. (73)
dem onstrated tha t explanted limbs were capable of morphogenetic 
maturation in a  chemically defined medium. The elimination of 
heterologous serum was an important step  In the standardization of 
experim ental conditions. It also simplifies pharmacodynamic evaluations 
within the system since interaction with serum proteins is excluded.
The submerged limb culture developed by Kwasigroch and coworkers 
(65) avoids many problems of the Trowell-type filter culture described 
above. Limbs a re  completely immersed in a defined culture liquor and are 
ro ta ted  in sealed bottles during incubation. This technique permits
uniform exposure of the organs to the culture milieu and therefore 
eliminates diffusion gradients and decreases in tra litte r  variability.
A significant advance in the development of limb bud culture for
use in discrete testing was the introduction of computerized image
analysis for data evaluation (67). Previous to this, laboratories have been 
resigned to  using complicated rating scales th a t require tedious subjective 
evaluations (89) or non-precise, sem i-quantitative methods (1). Although 
various s ta tis tic a l tests  are available for dealing with non-parametric 
data, evaluations based on user judgement calls carry high probability of 
error. Subtle differences a re  likely to  go unnoticed and reproducibility of 
experimental evaluations may vary within a single laboratory as well as 
among colleagues. With image analysis, specific endpoints (e.g., a rea  and 
shape of bone anlagen) may be measured quantitatively. The results are 
highly reproducible and do not rely upon the discretion of the user. An 
additional advantage to an established computerized system is that the 
data, once generated, does not require subsequent handling but may be 
autom atically analyzed for s ta tis tica l relevance.
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5-Fluorouraell
This study was designed to demonstrate the use of submerged 
culture of embryonic mouse limbs as an indicator of teratogenicity using a  
known teratogen, 5-fluorouraciI (FU). FU is identical in structure to the 
natural pyrimidine base uracil except that flourine is substituted for 
hydrogen a t  ring position five (Figure 1). Though not known to be toxic 
itself (83), FU is anabolized by a  variety of enzyme systems to yield at 
least two active metabolites (Figure 2). The deoxyribonucleotide, 
fluorodeoxyuridinemonophosphate (FdUMP), is a potent inhibitor of 
thymidylate synthetase, forming a ternary, covalent complex with the 
enzyme and its  cofactor, methylenetetrahydrofolate (100, 118; Figure 3). 
This enzyme catalyzes the transfer of a single methyl group from the 
cofactor to dUMP during de novo synthesis of dTMP. Inhibition of this 
reaction effectively blocks DNA replication resulting in "thymineless" cell 
death (18, 97). Modulation of this activity may be achieved a t various 
levels: the amount of reduced folate  available, intracellular pools of
nucleosides, availability of deoxyribose donors or acceptors (9, 135). 
These factors are the basis for a ttem pts to enhance the therapeutic 
efficacy of FU as an antimetabolite in cancer chemotherapy (7, 30, 37, 
60, 79, 138).
A second mode of action of FU is via incorporation of another 
active metabolite, fluorouridinetriphosphate (FUTP) into RNA. When 
present in mRNA, FU results in increased mutation ra te  and altered 
protein structure (11, 85). As a component of rRNA, FU prevents 
maturation of 45S precursor to functional 185 and 28S subunits (121, 142).
IS
Figure  X.
F igure  2.
F lu o ro u ra c i l  is  s im i la r  in s t r u c tu r e  to  the n a tu ra l  
pyrim id ine  base u r a c i l  except th a t  f lo u r In e  is  
s u b s t i t u t e d  fo r  hydrogen a t  r in g  p o s i t io n  f iv e .  From 
V a le r io te  and S a n te l l i  (136).
The anabolism of f lu o ro u ra c i l  (FUra) proceeds v ia  a 
v a r i e ty  of enzymatic pathways to  u l t im a te ly  y ie ld  a t  
le a s t  two a c t i v e  m e ta b o l i te s .  Fluorodeoxyuridinemono- 
phosphate (FdUMP) is  a  po ten t in h ib i to r  of the  
c r i t i c a l  enzyme, thym idyla te  sy n th e ta se .  F luoro - 
u r id in e t r ip h o s p h a te  (FtfTP) is  incorpora ted  in to  
c e l l u l a r  RNA. F luo rodeoxyurid ine tr iphosphate  (FdlTTP) 
is  incorpora ted  in to  c e l l u l a r  DMA but the p o te n t i a l ly  
c y to to x ic  n a tu re  of t h i s  in t e r a c t io n  is  not under­
s tood . From V a le r io te  and S a n te l l i  (136).
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In addition to  the interactions above, FU is also known to be 
incorporated into tRNA (134) and DNA (15) but the significance of these 
observations with regard to cytotoxicity remains to be understood (42, 
56). Thus the toxicity of FU potentially involves any of several
biochemical mechanisms. The question of which of the proposed
mechanisms is operational within a specific system is probably dependent 
on the ta rget tissue and its unique physiobiochemical disposition (136).
FU is catabolized via the same pathway as the natural analogs 
thymine and uracil (13; Figure 4). The first step, involving dihydrouracil 
dehydrogenase, Is rate-limiting in mammalian tissue (21, 83). Dagg et al. 
(23) demonstrated polygenic control of pyrimidine degradation In mice and 
suggested tha t  interstrain differences in response to FU were thus related 
to the genome of the animal modet.
FU has been recognized as a potent teratogen/embryotoxin when 
administered to impregnated females of several species a t  critical stages
of organogenesis (20, 58, 59, 111, 144, 145). Further, subteratogenic
doses of FU have been shown to increase the expressivity of mutant 
gene-mediated limb defects in mice (24, 40). In evaluation of the 
teratogenic e ffec t  of fluordeoxyuridine, an intermediate in the 
intracellular conversion of FU to FdUMP, Bro-Rasmussen e t  al, (10) 
regarded the primary cause of teratogenesis to be the drug's direct effect 
on vascularization. However, using avascular mouse limb bud culture, 
Knudsen and Kochhar (61) demonstrated dose-dependent Increase in cell 
death of subridge and peripheral mesenchyme following in vitro exposure 
of explanted limbs. Skalko and Jacobs (113) demonstrated a temporal
Figure 3.
Figure 4.
The active metabolite of fluorouracil, fluorodeoxyuridinemonophosphate, forms a 
covalent, ternary complex with the enzyme thymidylate synthetase and its  cofactor N5, 
N 10-methylenetetrahydrofoIate. The biochemical lesion thus produced prevents de novo 
synthesis of thymidylate required for DNA replication. From Valeriote and Santelli 
(136).
The catabolism of fluorouracil proceeds along the same pathway as the natural 
pyrimidine bases. The primary step, involving dihydrouracil dehydrogenase, is 
rate-limiting in mammalian tissues.
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relationship of inhibited DNA synthesis, embryonic cell death and 
embryolethality resultant from high-dose treatment with FU in utero. 
These studies offer evidence that teratogenic effects  of FU may result 
from cell death in situ. To date, the teratogenic effects  of FU 
administered in vitro have not been examined.
CHAPTER 2 
METHODS
Animals
Virgin ICR mice (Charles River) were maintained in a controlled 
environment (72 ±2°F, 60 10% relative humidity) with a 20h light (0200-2200h), 
4h dark cycle. Ovulation occurs at about the midpoint of the dark cycle. A 
shortened dark period decreases variability between animals and provides more 
accurately timed pregnancies (115). Since stage specificity of drug treatment is 
critically involved in experimental outcome (22, 147), this approach is beneficial 
for the maintenance of long-standing breeding colonies. One breeding male was 
housed with five females (minimum weight = 25g) which were examined daily 
between 0800 and lOOOh for the presence of copulation plugs (plug date * day 0 
of embryonic development, E0). Plug positive females were removed from the 
breeding colony and were maintained under identical conditions until autopsy. 
Mouse breeder blocs (Wayne Animal Food; Chicago, llinois) and tapwater were 
supplied ad libitum. Animals were randomly assigned to  experimental groups; 10 
lit te rs  were used per group.
FU Teratology
In vivo; On the morning of E l l  (0900-1000h) pregnant mice received a 
single i.p. injection of e ither 10, 20 or 40 mg Fll (dissolved in distilled water, 
Appendix A) per kg of body weight. Untreated control females were weighed 
but received no injection. On E17 (1300-1500h) animals were killed by cervical 
dislocation and maternal weights were recorded. Uteri were exposed via 
diagonal incisions extending bilaterally from the perineal body to the costal
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margin a t  the axillary line. The total number of implantation sites in each 
uterine horn was noted as were the number and position of resorptions. The 
uterus was opened with scissors and each fetus, freed of supporting tissues by 
transection of the umbilicus, was weighed to the nearest Q.Olg. Individuals 
were sexed and examined for gross malformations of the head, trunk and limbs 
with the use of a  Luxo illuminated magnifying lens. Fixation was accomplished 
by storage in 95% EtOH. Subsequent to fixation, gross dissection of the 
cranium was employed for examination of palatal defects. Soft tissue was 
digested with 2% KOH and skeletal elements were stained with Alizarin red 
then stored in glycerin/EtOH (Appendix B). Individual bones of each fetus were 
examined and subjectively scored on a  scale of zero (poor) to five (good) 
according to criteria  of size, shape and staining (Appendix B). Scores were 
summed to provide a total fetus rating.
In vivo/ln v itro ; On the morning of E l l  (0900-1030h), pregnant mice 
received a single i.p. injection of either 10, 20 or 40 mg FU per kg body weight. 
Treatment of individuals was administered a t 30 minute intervals with a 
maximum of four individuals trea ted  on any one day. This schedule compensated 
for the length of the autopsy procedure and allowed the  time of exposure to FU 
in utero to be equalized for all cases. Treated and untreated control mice were 
killed by cervical dislocation e ither on the afternoon of E l l  (1600-1800h) or the 
morning of E12 (1000-1200h).
In v itro : On the afternoon of E l l  (1600-1800h) untreated females were 
killed by cervical dislocation and fetuses prepared for limb culture. FU was 
dissolved directly in the culture medium and was administered for the duration 
of the culture period a t  concentrations of 0,002, 0.02, 0.2 or 2.0 mg/ml. 
Control cultures were similarly prepared but were maintained in untreated 
medium.
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In vitro, Thymine rescue: On the afternoon of E l l  (160Q-1800h)
untreated mice were killed and the fetuses removed for culture. FU was 
presented in the culture medium a t  a  concentration of 0.02 mg/ml. Thymine 
was also added a t concentrations of 0.002, 0.02 or 0.2 mg/ml. Control cultures 
were maintained in untreated medium or contained 0.2 mg/ml thymine only.
Limb Culture Technique
All glassware and equipment used to prepare cultures were carefully 
cleaned end autoclaved for 20 minutes a t  a medium temperature setting (125°, 
20 psi; National Appliance Co., model 8000-DSE). Procedures were performed in 
the aseptic environment of a ventilated hood (Environmental Air Control, Inc., 
Hagerstown, Md) previously scrubbed with 70% EtOH. Culture medium was 
prepared just prior to use (Appendix C). During culture preparation, fetuses 
were immersed in cold, sterile Hanks' balanced salt solution (Appendix D) which 
was filter sterilized (0.22 |im Millipore Swinnex, Bedford, MA) just before use.
At autopsy, the uterine horns were exposed and examined for resorptions, 
excised by transection of the cervix and placed immediately into cold Hanks'. 
The uterine margin distal to the placentas was opened with scissors; fetuses 
were removed, separated from supporting tissues, placed into fresh Hanks' 
solution, decapitated and transferred once more to fresh Hanks'. Using an 
Olympus dissection microscope, each fetus was transected just caudal to  the 
hepatic margin. Somites were carefully counted starting just caudal to the 
attachm ent of the hindlimb to the body flank. The first somite thus counted 
was designated 28. Only lit te rs  with an average somite number between 46-48 
(E ll)  or 50-52 (E12) were used in the studies. This allowed s tr ic t control of 
the stage specificity of experimental intervention.
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Forelimbs from one l it te r  of embryos were removed by two diagonal 
incisions across the upper thorax. Hindlimbs were similarly removed from the 
abdomen. Pooled fore- or hindlimbs were transferred into a sterile, 50 ml 
Wheaton bottle  and the Hanks' solution was carefully removed with a pipette. 
The limbs were rinsed with 2 ml of prepared culture medium which was also 
removed via pipette, After addition of 2.5 ml (E ll)  or 4 ml (E12) of culture 
medium, the bottle was sealed with a  rubber stopper and aluminum clasp (Oh of 
culture). The sealed bottles were mounted on a rotating cog (10 revolutions per 
minute) held within an incubator (Fisher isotemp Model 303) maintained a t 37°C 
for the duration of the three day culture period. Each bottle was gassed daily 
with a gas mixture of 50 or 20% Og, 5% COg and a balance of Ng. Forelimbs 
received the 50% Og mixture throughout the culture period. At Oh, hindlimbs 
received the 20% Og mixture; the 50% Og mixture was used on all other 
occasions. Aeration was accomplished by insertion of two 20g, H "  hypodermic 
needles -  one to serve as an inlet, the other an outlet port. The gas was 
administered through a  sterile Millipore filter (fluoropore, 0.2 pm) a t  a  flow rate  
of four liters  per minute. A slight positive pressure was developed in the 
bottles by removal of the outlet port about two seconds prior to removal of the 
inlet port. Before each aeration, limbs were disaggregated by brief shaking 
on a vortex mixer. At 72h cultures were opened and the culture medium 
removed via pipette. Limbs were rinsed with fresh Hanks' solution then fixed in 
Bouin's solution (Appendix B).
Tissue processing
Fixed limbs were decolorized in alcohol containing NH^OH, stained with 
alcian blue, cleared in acetic  acid/EtOH, dehydrated in an alcohol series and 
xylene and stored in cedarwood oil (Appendix E). Cedarwood oil was la ter
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removed by draining the limbs on filter paper. Clean glass slides were covered 
with a  thick layer of DePeX (GURR, Bio/Medical Specialties; Santa Monica, 
California) mounting medium and whole limbs were arranged within the medium 
and topped with a cover slip. Mounted limbs from all culture studies are 
illustrated in Figures 5-36.
Mounted slides were viewed with an Olympus microscope (mag = 40x) and 
the number of missing phalanges and metacarpals/metatarsals (ectrodactyly) or 
fused paw elements (syndactyly) were recorded for each l i t te r .  Specific 
quantitative data was obtained using an image analysis system (Leitz A.S.M.). 
A stage micrometer was mounted on a Bausch and Lomb microprojector and the 
image projected onto the digitizing pad was traced with 10 replications to 
calculate the magnification of the projection. The magnification value thus 
obtained was programmed into the computer's microprocessor and all subsequent 
actual measurements were automatically calculated. Seven limbs from each of 
seven lit te rs  per treatment group (total of 49 limbs per group) were randomly 
selected for measurement and the identity of each slide was not known until all 
measurements were made. Each limb was projected onto the digitizing pad and 
an outline trace of individual bone anlagen and the to ta l limb was made. These 
values were then used to compute, on a  per limb basis: (1) to ta l bone area 
(areas of all bone anlagen summed), (2) soft tissue area  (area of the total limb 
minus total bone area), (3) soft tissue/bone ratio (soft tissue area  divided by 
to ta l bone area) and (4) long bone/paw ratio  (sum of the areas for the scapula, 
humerus, radius and ulna divided by the areas for the carpals, metacarpals, and 
phalanges). Similar measurements were made for corresponding HL components.
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F igure  5,
F igure  6 .
F igure  7.
E12 in  v iv o / in  v i t r o  u n tre a ted  fo re lim b . Middle 
phalanges were always p re sen t  and d i s t a l  phalanges 
were sometimes observed (S = scap u la ;  H = humerus; E 
= ra d iu s ;  U = u ln a ;  C = c a rp a ls ;  h C lI I  = m etacarpal of 
d i g i t  I I I ;  PV = proximal phalanx of d i g i t  V; MPIII = 
middle phalanx o f  d i g i t  I I I } .
E12 in v iv o / in  v i t r o . 10 mg/kg t r e a te d  forelim b. 
T o ta l 1 imb a re a  was decreased coopered to  u n tre a ted  
c o n t ro l s .
E12 in v lvo / ln v i t r o . 20 mg/kg t r e a te d  fo re lim b. In 
a d d i t io n  to syndac ty ly  o f  neighboring  d i g i t a l  
components, fus ion  of m etacarpa ls-phalanges  was o f te n  
observed (arrow ).
F igure  8 . E12 in v iv o / in  v i t r o . 40 mg/kg t r e a te d  forelim b. Only
the  phalanges of d i g i t s  I I I  and IV remain. 
M etacarpals  I I  and I I I  a r e  fused (arrow ).
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F igu re  9.
F igure  10.
F igu re  11.
E12 in v iv o / in  v i t r o  u n tre a te d  hindlimb. Middle 
phalanges were sometimes p re sen t  (Pe = p e lv i s ;  F = 
femur; T = t i b i a ;  Fi = f ib u l a ;  Ta -  t a r s a l s ;
MTI = m e ta ta r sa l  of d i g i t  1; PV = proximal phalanx o f 
d i g i t  V).
E12 in  v iv o / in  v i t r o . 10 mg/kg t r e a te d  hindlimb. 
While t o t a l  1 imb and bone a reas  were decreased  
compared to  c o n t r o l s ,  the  percen tage  o f  m issing  paw 
elem ents was only m oderately  a f f e c t e d  a t  th i s  dose.
E l2 in v iv o / in  v i t r o , 20 mg/kg t r e a te d  hindlim b. With 
re sp ec t  to  the  previous trea tm ent group, t o t a l  limb 
and bone a reas  were not d i f f e r e n t  but e c tro d a c ty ly  was 
s u b s t a n t i a l l y  inc reased .
F igure  12. E12 in v iv o / in  v i t r o , 40 mg/kg t r e a te d  hindlimb. 
E c tro d ac ty ly  was g r e a t l y  Increased  a t  t h i s  dose 
compared to  o th e r  E12 groups.
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F igu re  13. E l l  in v iv o / in  v i t r o , u n tre a ted  fo re lim b . Phalanges I
and V were r a r e ly  p re s e n t .
F igu re  14. E l l  in v iv o / in  v i t r o , 10 mg/kg t r e a te d  fo re lim bs.
T o ta l  limb a rea  was u n a ffec ted  by trea tm en t w ith  FU.
F igure  15. E l l  in v iv o / in  v i t r o . 20 mg/kg t r e a te d  forelim b.
Growth of d i s t a l  paw s o f t  t i s s u e  was not in h ib i te d ,  
but phalangeal c a r t i l a g e  development was o f te n  
m iss ing .
F igu re  16. E l l  in v iv o / in  v i t r o , 40 mg/kg t r e a te d  forelim b.
T o ta l  limb a re a  was decreased  compared to  u n tre a ted  
c o n tro ls  due to  lo s s  of a re a  in both c a r t i l a g e  and 
s o f t  t i s s u e .  Note the  b asa l  fus ion  o f m etacarpals  
11, 111 and IV (a rrow ).
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F igure  17.
F igure  18.
F igure  19.
E l l  in v iv o / in  v i t r o , u n tre a te d  hindlimb. As in 
corresponding fo re lim bs, PI and V were r a r e ly  p re s e n t .
E l l  in v iv o / in  v i t r o , 10 mg/kg t r e a te d  hindlim b. This 
trea tm ent g e n e ra l ly  d id  not dem onstrate  d e le te r io u s  
e f f e c t s  on limb growth.
E l l  in v iv o / ln  v i t r o , 20 mg/kg t r e a te d  hindlim b. 
Shape F ac to rs  of ind iv idua l bone anlagen were not 
c o n s i s te n t ly  a f f e c te d .
F igure  20. E l l  in v iv o / in  v i t r o , 40 mg/kg t r e a te d  hindlim b. In 
a d d i t io n  to  increased  e c t ro d a c ty ly ,  f ib u la e  and/or 
t a r s a l s  were o f te n  a b sen t .
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F igu re  21.
F igure  22.
F igu re  23.
E l l  in v i t r o  0.002 mg/ml t r e a te d  fo re lim b. Chronic 
in v i t r o  exposure to  FU re s u l te d  in increased  
incidence  of ED and decreased  a reas  fo r t o t a l  1 imb, 
t o t a l  bone and s o f t  t i s s u e .
E l i  in v i t r o , 0.02 mg/ml t r e a te d  fo re lim b. Treatment 
w ith  FU (fid not c o n s i s t e n t ly  a f f e c t  the  shape of 
ind iv idua l bone anlagen .
E l l  in v i t r o , 0 .2  mg/ml t r e a te d  fo re lim b . As the  s iz e  
o f  proximal s t r u c tu r e s  was g r e a t ly  decreased , d i s t a l  
paw components were e n t i r e l y  e l im in a te d .
F igu re  24. E l l  in v i t r o , 2 .0  mg/ml t r e a te d  fo re lim b. In a d d i t io n
to  t o t a l  e l im in a t io n  of the  paw, absence of the 
rad iu s  and u lna o f te n  occu rred .
m m m
%*:—r'-T.-r^-'VLVA* :\r--.
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F igure  25. in v i t r o , 0.002  mg/ml t r e a te d  hindlimb. 
Ind iv idual bone a re a s  were decreased  by in v i t r o  
trea tm en t.
F igure  26. E l l  in v i t r o  0.02 mg/ml t r e a te d  hindlim b. In v i t r o
treatm ent w ith  FU was com pletely  p ro h ib i t iv e  to  
phalangeal form ation.
F igu re  27. E l l  in v i t r o , 0.2 mg/ml t r e a te d  hindlim b. As in v i t r o
dose of FU in c reased ,  the  formation of a l l  long bone 
anlagen decreased .
F igu re  28. E l l  in v i t r o , 2 .0  mg/ml t r e a te d  hindlim b. C a r t i la g e  
formation was s e v e r ly  decreased  throughout the  e n t i r e  
limb.
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Figure  29.
F igure  30.
F igure  31.
F igure  32.
E l l  in v i t r o  -  Thymine rescue , co n tro l  fo re lim b. 
A ddition  of 0 .2  mg/ml thymine to  forelim b c u l tu re s  
r e s u l te d  in enhanced development of phalanges.
E l l  in v i t r o  -  Thymine rescue . Forelimb c u l tu r e s  
co n ta in in g  0,02 mg/ml FU a l s o  rece ived  0.2 tng/ml 
thymine. Formation o f  phalanges I I —IV was g r e a t ly  
enhanced compared to  c u l tu re s  co n ta in in g  FU a lone .
E l l  in v i t r o  -  Thymine rescue . Although in d iv id u a l
bone a reas  were u su a l ly  not inc reased  w ith the 
a d d i t io n  of 0.02 mg/ml thymine to  FU -trea ted  forelim b 
c u l tu r e s ,  t o t a l  bone a rea  was inc reased .
E l l  In v i t r o  -  Thymine re scu e .  A ddition of 0.002 
mg/ml thymine to  fo relim b c u l tu re s  concom itantly  
t r e a te d  w ith  0.02 mg/ml FU d id  not enhance c a r t i l a g e  
growth and development. C onverse ly , ED o f m etacarpals  
111 and IV increased  in t h i s  m i l ie u .

40
F igu re  33. E ll in v i t r o  -  Thymine re scu e , c o n tro l h indlim b.
A ddition  of 0 .2  mg/ml thymine re s u lte d  in a 
p a radox ica l in c rease  in e c tro d a c ty ly  o f  some paw 
elem ents but long bone models were increased  in s iz e .
F ig u re  34. E ll  in v i t r o  -  Thymine rescu e . Form ation of phalanges
in  F U -trea ted  hindlim b c u ltu re s  was enhanced by 
concom itant a d d itio n  o f 0 .2  mg/ml thymine.
F igure  35. E l l  in v i t r o  -  Thymine rescu e . Though phalanges were
ra re ly  p re sen t upon a d d itio n  o f equim olar concen­
t r a t io n s  o f thymine and FU, absence o f long bone 
components and m e ta ta r s a ls  was g re a t ly  decreased .
F igu re  36. E l l  in v i t r o  -  Thymine re scu e . The most n o teab le
b e n e f it  o f 0.002 mg/ml thymine added to  FU tre a te d  
hindlim bs was in c reased  form ation o f long bone 
an lagen .
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Biochemical studies
On the morning of G il, pregnant mice received 10, 20 or 40 mg/kg FU by 
single i.p. injection. Treated and untreated  control animals were prepared for 
culture 7h la te r. Additional cultures were prepared from untreated  females; 
these limbs were exposed to FU in vitro a t  doses of 0.002, 0.02 or 0.2 mg/ml. 
Limbs were harvested a t various times following initiation of culture: Oh
(control, 10, 20 and 40 mg/kg in vivo), 36h (control, 20 mg/kg in vivo/in vitro,
0.02 and 0.2 mg/ml in vitro) and 72h (all groups). At harvest, limbs were
disaggregated by shaking, counted, rinsed with a phosphate buffer (Appendix F) 
placed into 1.5 ml Eppendorf centrifuge tubes, and stored quickly in buffer at 
-40°C.
For processing, tissues were thawed and briefly spun in an Eppendorf 
centrifuge to fac ilita te  removal of the storage buffer. Strips of filte r paper
were used to blot dry any remaining liquid. Tubes containing tissue were
weighed to the nearest O.OOOlg on a  M ettler balance. (Subsequent weighing of 
the empty tube provided the tissue wet weight). Each tissue sample received 
350 pi of 10 mM TRIS buffer, pH 8.4 and a homogenate was prepared on ice by 
sonlcation for one minute using the interm ediate tip of a  Fisher sonic 
dismembrator (Model 300) a t a  setting of 55%. Tubes were allowed to s it for 
two minutes to reduce foaming then the homogenate was divided into two 100 pi 
aliquots, labeled DNA or protein, which were refrozen.
DNA: Salmon sperm DNA (3.57 mg/ml 10 mM TRIS buffer), provided by 
Dr. Phillip Musich, Department of Biochemistry, was diluted with 10 mM TRIS 
buffer to provide a standard stock solution of 420 pg/ml. The effective 
concentration of this stock solution was determined by measuring absorbance of 
a  1:19 diluent (stock:10 mM TRIS) a t  260 nm (Appendix G). Standards were 
stored in 1 ml lots a t -40°C.
43
For determ ination of sample DNA concentrations, the 100 pi samples of 
tissue homogenates were thawed and 500 pi of cold 5% PCA was added. 
Samples were placed on ice for five minutes and spun in an Eppendorf 
centrifuge for four minutes. Supernatants were removed via aspiration with a 5 
cc syringe fitted  with a  20g needle. The remaining pellet was resuspended in 
100 pi of 5% PCA by sonication for 15 seconds. Tubes were immersed for 15 
minutes in a  75°C w ater bath then centrifuged for four minutes. From each 
tube, supernatant aliquots of 10, 20 and 40 pi were pipetted into new Eppendorf 
tubes and the volume of each was increased to 100 pi with 5% PCA. 
Diphenylamine (DPA) reagent was prepared immediately prior to use {Appendix 
H) and 200 pi of the dye was added to  each diluted sample. Internal standards 
were prepared by pipetting 5, 10, 20, 40 and 60 pi of thawed DNA stock solution 
into clean tubes whose volume was increased to  100 pi with TRIS buffer. These 
standards were then processed along with sample unknowns. External standards 
consisted of 5, 10, 20, 40 and 60 pi of thawed stock brought to  100 pi volume 
with 5% PCA. To these tubes was added 200 pi of DPA reagent. Blanks were 
composed of 100 pi of 5% PCA and 200 pi of DPA reagent. Following addition 
of the dye, all samples, standards and blanks were shaken for one minute on a 
Eppendorf shaker and color was allowed to  develop overnight a t room 
tem perature. On the following morning, 200 pi from each tube was loaded into 
a tissue culture plate (Falcon, M icrotest II) which was read on a  T ltertek  
Multiskan p la te  reader fitted  with a  590 nm in terference filte r . Standard 
concentrations vs. absorbance tODggg) were p lotted to  test for linearity  of 
measurements (Figure 37). Values obtained for all standards were pooled to 
determ ine average absorbance value obtained per pg of DNA. This value was 
used along with appropriate dilution factors to calculate a  single constant tha t, 
when multiplied by the absorbance for any sample aliquot of 20 pi, would yield
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F ig u re  37. DMA stan d a rd s  were measured w ith  each s e t  of unknown
sam ples. S tandard  co n ce n tra tio n  <(ig) was p lo tte d  
a g a in s t absorbance (O D .gJ to  t e s t  fo r l in e a r i ty  o f 
a ssay  measurements.
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the amount of DNA In the original tissue sample. The to ta l sample DNA was 
divided by the number of limbs in the sample to provide the amount of DNA per 
limb In each experiment.
Protein; A standard stock solution of bovine serum albumin in lOmM 
TRIS buffer <1 mg/ml) was prepared and stored a t  -40°C in 1 ml lots. Actual 
concentration was determined by reading absorbance of 1:1 diluent (stock: 10
mM Tris buffer) a t  280 nm (Appendix G).
Sample homogenates and standards were thawed and from each was taken 
2.5, 5, 10, 15, 20 and 25 pi aliquots; dHOH was added to  bring each sample to 
800 pi. Blanks contained 800 pi of dHOH. Bradford dye reagent was filtered  
(Millipore filter, 0.45 pm) immediately before use and 200 pi was added to 
samples, standards and blanks followed by brief shaking on a vortex mixer. 
A fter standing for 15 minutes a t  room tem perature, 200 pi of each sample was 
read in a T itertek  Multiskan pla te  reader with an in terference filte r of 590 nm. 
Standard concentrations vs. absorbance (ODggg) were plotted to te s t for 
linearity  of measurements (Figure 38). Values obtained for all standards were 
pooled to determine the average absorbance value obtained per mg protein. 
This value was coupled with dilution factors to provide the constant needed to 
compute the protein concentration of the original homogenate. The total 
sample protein was divided by the number of limbs in the sample to determine 
the amount of protein per limb for each experiment.
S ta tistica l evaluation
Data files were built on a DEC PDF 11/70 computer system using a 
self-constructed BASIC2 program for entering, sorting and calculating data 
param eters. Files were submitted for batch processing to an IBM 4341
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F igu re  38. P ro te in  s tan d a rd s  (bovine serum album in) were measured
w ith  each s e t  o f unknown sam ples. S tandard  
c o n c e n tra tio n  (pg) was p lo t te d  a g a in s t absorbance <«w t0  t e s t  for l in e a r i ty  o f a ssay  measurements.
Protein standard curve
. 50 0 -
.400 -
.3 0 0 -
.2 0 0 -
. 100 -
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49
(operating system OSVS1) computer via remote job entry . S ta tis tica l evaluations 
were performed using SAS and SPSSX packages. Param etric data were 
analyzed for s ta tis tic a l significance using one-way analysis of variance. 
Comparisons between groups were made with the Student Neuman-Keuls te st. 
Kruskal-Wallis one-way analysis of variance was used to  evaluate the original 
data  derived from examination of Alizarin red stained bones of E l7 fetuses. 
Incidence of missing or fused limb components was s ta tis tica lly  examined with 
Chi-Square tests  or, when appropriate due to small cell size, with Fisher's exact 
te s t. The type 1 error ra te  chosen was a  = 0.05.
CHAPTER 3 
RESULTS
In Vivo Teratology
The effect of FU on the development of mouse fetuses in utero is presented in 
Table 1. M aternal weight gain, measured between E l l  and E17, was modestly 
increased when 10 mg/kg FU was administered to dams but was substantially decreased 
a t 40 mg/kg. Fetal m ortality was slightly decreased compared to controls following 
administration of 10 mg/kg FU, but increased more than 10 fold when dams received 
40 mg/kg FU, Neither of these param eters was affected  by the medium dose, 20 
mg/kg. Average wet weight of viable fetuses exposed to  40 mg/kg FU was decreased 
compared to the control value by about 50% while lower doses had no effec t.
Examination of E17 fetuses for gross malformations of the head and trunk 
revealed tha t e ffec ts  were generally res tric ted  to  treatm ent with 40 mg/kg. The 
more severe e ffec ts  included micrognathia (100%), reduced or absent eyes (100%) and 
auricles (96%), ta il defects (shortening and ,fkinkingn due to malformations of 
vertebrae, 99%) and c left palate  (96%). Exencephaly (50%) and omphalocoele (11%) 
were also present. The lower doses had little  noticeable e ffec ts  on these structures 
but c le ft palate was found in the 20 mg/kg group (2%), and ta il defects were found in 
both 10 and 20 mg/kg (2% and 4% respectively).
Of greater in terest were the e ffec ts  of FU on limb development. The most 
pronounced deformity was ectrodactyly (ED), which presented in a dose-dependent 
manner (Table 1). The incidence of ED in hindlimbs (HL) was greater, (20 mg/kg-18%, 
40 mg/kg-99% of fetuses) than in forelimbs (FL) (20 mg/kg-8%, 40 mg/kg-61%) with 
treatm ent on E l l .  The increased sensitivity of hindlimbs to FU was also dem onstrated 
by the incidence of syndactyly (SD) following treatm ent with 20 mg/kg (FL-6% vs. 
HL-18%) but was not apparent for the 40 mg/kg group (FL-28%, HL-25%). This
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TABLE 1 -  TERATOGENIC EFFECTS OP FU AIMIMSTERED ON E l l 8
iK EA TJ/err m y te r h a l  h  im p la n ta t io n  v i a b l e  P H c a r r  _ f e t a l  h  p o r e lw b *  h in d l i s ©0 c l e f t  „
O O JP S  WEIGHT GAIN SITES FETUSES RE9CKBED WET WEICMT KM ED SO FP MB ED SD PD TAIL PALATE
UNTREATED
CCNTKXS 1 7 .3  *  4 .5  127 122 3 .9  1 .1  * 0 .1  -  -  -  -  -  -
10 m g/kg  2 1 .0  ± 3 . Id  146 145 0 .7  1 .1  ± 0 .1  -  -  -  -  0 .7  1 .4  -  2 .1
20 n « /k g  1 6 .3  ± 4 .1  130 124 4 .6  1 .1  £  0 .2  0 .S  B . l  5 .7  -  0 .8  1 7 .8  1 7 .8  3 .3  4 .0  2 .4
40 m g/kg* 7 .9  ± 3 .8 d 148 79 4 6 .1  0 .6  ± 0 .1 d  7 2 .2  6 0 .8  2 7 .9  2 .6  7 7 .3  9 8 .8  2 6 .4  -  9 8 .7  9 6 .0
.  I n d iv id u a l  f e t u s e s  M ere th e  u n i t  o f  m e a su re . 
c  V a lu e s  e x p re s s e d  a r e  mean ( g r a n s )  ± SD. 
d  V a lu e s  e x p re s s e d  a r e  p e r c e n ta g e s .
V a lu e s  a r e  s i g n i f i c a n t l y  d i f f e r e n t  from  u n t r e a t e d  c o n t r o l s  (p  < 0 .0 5 ) .  
O th e r  d e f e c t s  in c lu d e d :
M ic ro g n a th ia  -  100%
R e d u c e d /a b se n t ey e  -  100%
R e d u c e d /a b se n t a u r i c l e  -  96.2%
C h p h a to e o e le  -  11.3%
E x en cep h a ly  -  50%
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discrepancy may be explained however in light of the extrem e ra te  of ED found in 
hindlimbs a t the 40 mg/kg dose (99%). This may also account for the absence of 
demonstrable polydactyly in HL from fetuses exposed to 40 mg/kg though this dosage 
did result in a  low expression of PD in FL (3%) and a similar result was observed in 
HL trea ted  with 20 mg/kg (3%). D ifferential expression of micromelia (MM) in FL 
(72%) vs. HL (77%) was not noticed, even a t 40 mg/kg. Only 1 fe tus in the 20 mg/kg 
group was reported to  exhibit FL and HL MM. Thus, treatm ent of dams with FU on 
E l l  had extrem e e ffec ts  on normal fe ta l growth, viability and paw morphogenesis if 
40 mg/kg was administered but was marginal a t doses of 10 or 20 mg/kg.
Bones of Alizarin red stained E17 fetuses were subjectively ra ted  for e ffec ts  of 
FU on properties of size, shape and staining potential (Table 2), No observable 
defects were reported a t  10 mg/kg. Both fo re- and hindpaws were reduced by 20 
mg/kg but o ther bones were unaffected. Treatm ent with 40 mg/kg resulted in 
substantial reduction of ratings for all bones. The decreased ratings most often 
reflec ted  reduced size: crania displayed enlarged fontanelles and suture lines, all
mandibles exhibited micrognathia; ribs were incomplete or missing; vertebrae were 
small and misshapened. Examination of sternabrae presented a unique observation. 
Boney segments were enlarged and fused into a  single, inappropriate mass compared to 
the smaller, independent sections observed in control animals. Limb bones also showed 
significant reduction a t  40 mg/kg. Most affected  were the paws, the hindpaw more 
severely than the forepaw. Of all long bones, the fibula was most affected . This 
corre la tes with Hampe's (47) observations th a t the fibula is most sensitive to  
experim ental changes in tissue mass. When the evaluations for individual bones were 
combined to  yield a to ta l fetus rating, 40 mg/kg produced a value tha t was about 50% 
of the value assigned to controls. The to ta l fetus rating was unaffected by smaller 
doses.
TABLE 2 -  EFFECT CF FU ON THE APPEARANCE OF ALIZARIN RED-STAINED BONES OF E17 MOUSE FETUSES*
U ntrea ted
S kull
C on tro l
5
10 mg/kg 
5
20 mg/kg 
5
40 mg/kg 
3
Jaw 5 5 5 2
Sternum 5 5 5 2
Ribs 5 5 5 1
V erteb rae 5 5 5 2
Scapula 5 5 5 2
Humerus 5 * 5 5 3
Radius 5 5 5 3 .5
Ulna 5 5 5 3 .5
Long Bones 20 20 20 13.1
Paw 5 5 4 2
Iliu m S 5 5 3
Femur 5 5 5 3
T ib ia 5 5 5 2
F ib u la 5 5 5 2
Long Bones 20 20 20 11.5
Paw 5 5 4 0.5
T o ta l F e tu s 74.4 75.0 73.2 37.8
* V alues expressed  a re  th e  median.
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Digital E ffects
The incidence of ED and SD was examined for individual phalanges in E17 
fetuses. These results were compared to  the expression of ED/SD in the phalanges 
and m etacarpals/m etatarsals (MC/MT) of cultured limbs, Forelimbs of fetuses allowed 
to develop in utero until E17 were the most resistan t to treatm ent with FU (Table 3), 
Few instances of ED were observed in fetuses trea ted  with 20 mg/kg, but phalanges 
were significantly affected  a t 40 mg/kg. In contrast, in u tero  treatm ent followed by 
culture of explanted limb buds on E12 or E l l  resulted in dose-dependent ED with 
obvious expression in both m etacarpals and phalanges. This expression was least 
pronounced in MC- II-IV (E12) and MC-III.IV (E ll) . In each case, the e ffec ts  were 
g rea ter in limbs cultured on E l l .  When FU was chronically administered in v itro , the 
deleterious nature of the chemical on the developing paw was most evident. 
Phalanges were virtually eliminated although digits III and IV dem onstrated resilience 
in a  few cases trea ted  with 0.002 or 0.02 mg/ml. The corresponding MC in these 
groups were also most reslsten t to treatm ent, but o ther MC were greatly a ffec ted . In 
all studies, the severity  of expression followed a consistent pattern , digit I > V > II > 
IV > III, th a t was observed in both phalanges and m etacarpals. Also, responses 
generally revealed dose-dependent trends.
The highly teratogenic nature of FU administered in v itro  provoked in te rest in 
whether the insult produced might be dampened by simultaneous administration of 
thymine. Thymine control cultures (containing 0.2 mg/ml Thymine) dem onstrated a 
substantial decrease in phalangeal ED compared to  untreated  controls (e.g., 99% vs. 
75% and 94% vs, 67% for digits I and V respectively; Table 3), In cultures trea ted  
with both FU and thymine, g rea tes t improvement was noted when thymine 
concentration exceeded FU concentration by one log dose (0,2 mg/ml Thy + 0.02 mg/ml 
FU). With the exception of P-I, P-V, digital formation was substantially improved 
compared to  cultures receiving 0.02 mg/ml FU only. The elem ents showing the largest
inin
TABLE 3 -  INCIDENCE OF BQRELINB BCIRQDACIYLY IN MICE TREATED WITH FU ON E I la
PHALANGES METACARPALS
1 I I I I I IV V I I I I I I IV V
E17 IN VIVO
Untreated - - - - - - - - - -
10 mg/kg - - - - - - - - -
20 mg/kg 2 .4 1 .6 1 .6 2 .4 1 .6 - - - -
40 mg/kg 39.8 22.5 12.7 17.1 30.0 - - — — —
E12 IN VIVO/IN VITRO
Untreated 7 .1 1 .1 - - 3.6 0.5 - - - 0 .5
10 mg/kg 35.2 4 .0 2 .8 1 .2 11 .8 9 .5 1 .7 0 .6 0 .6 0 .6
20 mg/kg 42.5 10 .6 5 .6 7 .8 33.5 6 .1 1.1 0 .6 0 .6 8 .4
40 mg/kg 90.8 47.6 43.8 54.6 42.2 53.0 11.9 3 .2 11.9 56.2
E l l  IN VIVO/ IN VITOD
U ntreated 99.0 21 .0 3 .7 4 .7 94.3 14.6 0 .6 - 0 .6 1 .6
10 mg/kg 90.8 27.2 5 .2 9 .8 72.9 38.5 5 .7 0 .6 1 .1 12.3
20 mg/kg 96.4 36.8 11.4 24.4 88 .1 49.8 12 .0 - 4 .7 34.2
40 mg/kg 100 61.3 52.1 55.5 82.1 63.6 34.1 26.1 26.6 73.5
E l l  IN VITRO
0 .002 mg/ml 99.5 98.9 78.2 85.1 99.5 94.3 28.8 1 .8 1 .2 79.9
0 .0 2 mg/ml 100 100 92.8 95.8 100 98.8 56.3 2 .4 4 .2 96.4
0 .2 mg/ral 100 100 100 100 100 100 77.1 24.8 43.1 96.0
2 .0 mg/ml 100 100 100 100 100 100 82.5 34.2 55.0 96.6
E l l  IN VITRO -  THYMINE RESCUE 
0 .2  mg/ml THY K 74.9 7.7 0 .6 66.7 16.4 2 .2 1 .1 6 .6
0 .2 mg/ml THY + FIL 
mg/ml THY + FUZ
98.8 80.4 38.0 66.9 97.6 74.2 8 .6 - 1 .8 49.7
0 .02 100 99.5 97.8 97.8 100 95.0 2 2 .6 0 .6 4 .0 51.5
0.002 mg/ml THY + FIT 100 100 100 100 100 100 55.7 10 .2 34.7 91.9
a Values expressed  a re  p e rc en ta g e s . 
C u ltu re s  co n ta in ed  0.02 mg/ml FU.
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improvement were those th a t originally seemed most resisten t to  FU. Thus, recalling 
the relative sensitivies of the phalanges (I > V > II > IV > III), P-I and P-V showed no 
improvement, P-Il improved by 20%, P-1V by 29% and P-1U by 55%. Comparably, MC-I 
improved by 25%, MC-V by 46% and MC-I1 by 48%. ED of MC-1II, IV had minimal 
expression already and therefore, it  was not possible to  monitor real improvement 
following addition of thymine. Addition of an equimolar concentration of thymine 
resulted in decreased ED for MC-1I and V only. O ther elem ents remained unaffected. 
When the concentration of thymine was one log dose less than th a t of FU, ED 
remained the some or worsened. No phalanges developed in this milieu and MC-1II and 
IV had increased ED, the change being more pronounced for the more sensitive 
elem ent, MC-IV.
The results for hindlimbs were similar but generally more severe (Table 4). 
Responses were dose dependent unless the outcome was so severe tha t all elements 
were eliminated (e.g., E l l  in v itro-phalanges). As for forelimbs, the severity  of the 
e ffe c t maintained a consistent pa ttern  for both individual paw elements (digit I > V > 
II > IV > III) and type of experiment (E l l  in v itro  > E l l  in vlvo/in vitro > E12 
in vitro  > E17 in vivo.). In hindlimbs of E17 fetuses, two cases of ED appeared a t  10 
mg/kg and ED for the higher doses was increased compared to  forelimb values. This 
enhanced expression of hindlimb ED continued in E l2 in vlvo/in v itro , E l l  in vivo/in 
vitro and E l l  in v itro  studies and was most obvious in the more sensitive paw 
elements. For example, in E12 cultures a t 10 mg/kg, ED of P-I was FL-35%, HL-94% 
while ED for P-IH was FL-2.8%, HL-1.7%.
In contrast to the previous forelimb data, addition of 0.2 mg/ml thymine to 
hindlimb cultures resulted in increased ED of phalanges and m etatarsals compared to 
un treated  controls. However, when th a t dose of thymine was added to cultures 
containing 0.02 mg/ml FU, the incidence of ED decreased compared to  cultures with 
FU alone. Even when 0.02 or 0.002 mg/ml thymine was added, ED of MC-II, III and IV
TABLE 4 -  INCIDENCE OF HINDLIP.B BCIBODACITfLY IN MICE TREATED WITH FU ON E lla
PHALANGES METATARSALS
E17 IN VIVO
1 I I I I I IV V I 11 I I I IV V
U ntreated - - - - - - - - - -
10 rag/kg - - - - 1 .4 - - - - -
20 mg/kg 10 .8 2 .0 4 .4 4 .0 8 .9 - - - - -
40 mg/kg 80.4 46.8 15.2 55.1 67.7 - — — - -
E12 IN VIVO/IN VITRO
U ntreated 79.4 1 .1 0 .5 0 .5 21 .2 4 .2 0 .5 - - 3 .2
10 mg/kg 94.1 6 .0 1 .7 3 .8 54.1 15.2 1 .7 0 .6 - 5 .4
20 mg/kg 89.8 17.7 3 .8 2 .7 62.9 46.2 12.4 1 .6 3 .2 47.8
40 mg/kg 100 96.0 83.7 93.9 99.0 98.5 63.3 18.7 54.1 91.9
E l l  IN VIVO/IN VITRO
U ntreated 97.9 43.7 19.1 20.5 93.7 40.2 6 .4 0 .7 3 .6 42.3
10 mg/kg 94.5 47.6 15.5 29.9 87.3 57.5 11 .1 0 .6 7 .2 45.9
20 mg/kg 97.0 54.3 19.6 28.7 92.1 68.3 20 .2 3.7 15.9 59.8
40 ng/kg 98.8 84.6 67.6 77.2 100 93.9 69.8 29.1 59.3 94.5
E l l  IN VITRO
0 .002  mg/ml 100 100 100 100 100 100 70.7 12 .1 20 .1 100
0 .0 2  mg/ml 100 100 100 100 100 100 80.2 38.3 50.3 100
0 .2  mg/ml 100 100 100 100 100 100 93.5 51.7 56.3 98.7
2 .0  mg/ml 100 100 100 100 100 100 98.6 83.6 82.3 100
E l l  IN VITRO -  THSMINE RESCUE 
0 .2  mg/ml THY . 100 58.8 21.7 33.1 100 85.6 31.3 6.9 14.4 76.3
0 .2  tog/ml THY + FIT 93.0 86.7 81.8 86 .0 91.6 92.3 37.1 0 .7 7 .8 92.3
0.02 mg/ml THY + FIT 
0.002 mg/ml THY + FU
100 100 99.4 98.2 100 100 38.1 2 .4 19.6 99.4
100 99.3 100 100 100 100 74.0 2 2 .0 27.3 100
. Values expressed  a re  p e rc en ta g e s . 
C u ltu re s  co n ta in ed  0.02 mg/ml FU.
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decreased. Although appreciable decreases in phalangeal ED were not noted a t  the 
lower doses of thymine, a  few sporadic cases of phalangeal development were found.
A high incidence of SD in forelimb phalanges was observed between digits II and 
III (20%) and III and IV (16%) in E17 fetuses trea ted  with 40 mg/kg (Table 5). All 
o ther treatm ent groups had only sporadic phalangeal SD. Fusion of m etacarpals was 
frequently observed in In vivo/in vitro cultures. This usually involved fusion of the 
basal regions of otherwise distinct cartilages (Figure 16), but to ta l fusion of 
neighboring components was observed (Figure 8). Expression of SD a f te r  Jn  vitro  
trea tm en t was rare.
Enhancement of hindlimb SD was evident in in vivo and in vivo/in vitro 
experiments (Table 6). While values for in vitro studies a re  included and indicate 
potential for fusion under these conditions, it is im portant to realize the lim itation of 
the sample size. For example, a t  0.2 mg/ml in v itro , SD of MT-1V.V is reported to  be 
67% but actually refers to fusion involving two of th ree MT-V's present. Dose 
responses were most apparent in the phalanges of E17 fetuses, but were not always 
dem onstrated in cultured limbs due to the high levels of ED in the la tte r .
S
Polydactyly of digits I or II was observed in E17 fetuses treated  with 40 mg/kg 
(forelimbs) or 20 mg/kg (hindlimbs; Table 1). E l2 cultured limbs from fetuses trea ted  
in u tero  with 10 mg/kg displayed similar duplications (Figure 39). This e ffec t was not 
observed in any other culture experiments.
Image Analysis
The individual bone anlagen of cultured fore- and hindlimbs were evaluated for 
e ffec ts  on area  or shape using quantitative image analysis. In vivo treatm ent with FU 
on E l l  resulted in a dose-dependent decrease in the size of forelimb bones in nearly 
all cases (Table 7). The defects observed with E l l  in v itro  trea ted  limbs were more 
severe than those for E l l  in vivo/in vitro. All elem ents displayed significant
<31LO
TABLE 5 -  INCIDENCE CP BCRELU® SYNEMCTXUf IN MICE TREATED WITR FU ON E lla
PHAMNGES METACARPALS
E17 IN VIVO 
U ntrea ted  
10 mg/kg 
20 ng/kg 
40 iqg/kg
E12 IN VIMO/IN VITRO 
U ntrea ted  
10 mg/kg 
20 nfc/kg 
40 mg/kg
E l l  IN VIYO/IN VITRO 
U ntrea ted  
10 mg/kg 
20 mg/kg 
40 mg/kg
E l l  IN VITBO 
0.-002 mg/ml 
0 .0 2  mg/ml 
0 .2  mg/ml 
2 .0  mg/ml
I - I I
0 .4
1.1
*
*
*
*
*
*
*
*
II-III
2.0
19.7
3 .4
0 .7
2.8
3 .3
*
*
*
*
I1 I-IV
0.4
16.2
0 .6
5 .6
3 .4
2 .7
*
*
IV-V
0.4
0 .9
*
1 .9
3 .2
*
*
I - I I I I - I I I
2.8
35.0
3 .3  
2 .9
4 .4
*
III-1 V
6.2
33.1
2 .7
4 .0
0 .6
1.0
IV-V
12.7
61.7
2 .9
6 .3
21.7
«
*
*
E l l  IN VITRO -  THYMINE RESCUE
mg/ml Tfflf "  -
mg/ml TOY + FUjJ *
*
0.2  
0.2
0.02 mg/ml THY + FUjT 
0.002 nfc/ml THY + FU
*
*
•  * *  *
*90 -  100% o f elem ents were m issin g
*
*
£
b Values expressed  a re  p e rcen tages o f  rem aining d i g i t s .  
C u ltu re s  co n ta in ed  0.02 mg/ml FU.
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Figure 39. Polydactyly of digit II farrow) was observed in E12 in 
vivo/in vitro . 10 mg/kg trea ted  forelimbs. Similar defects 
were observed in vivo but only following treatm ent with 20 
mg/kg (hindlimbs) or 40 mg/kg (forelimbs).

CMto
TABLE 6 -  INCIDENCE OE HINDLIIVB SYNDACTYLY IN MICE TREATED WITH FU ON E ll
PHALANGES METATARSALS
E17 IN VIVO
I - I I I I - I I I I I I - IV IV-V I - I I I I - I I I I I I - IV IV-V
U ntrea ted - - - - - - -
10 mg/kg - 0 .7 - - - - - -
20 mg/kg - 11 .8 11 .8 0 .4 - - - -
40 mg/kg 14.3 35.7 66.5 3 .7 — — — -
E12 IN VIVO/IN VITHO
U ntreated - 0 .5 - - - - - -
10 mg/kg • - - - 0 .7 - - -
20 mg/kg - 2 .6 2.3 - - - 10 .6 1 .0
40 mg/kg * 25.0 2 . 2* « * 26.0 50.0 *
E l l  IN VIVO/IN VITHO
U ntreated * 1 .2 - « — - — -
10 mg/kg * 10 .6 2 2 .6 - 1.3 3 .7 6 .0 3 .1
20 ng/kg * 9 .3 26.7 • 1.9 5 .3 1 .4 12 .1
40 mg/kg * 8 .3 16.2 * • 26.5 34.8 •
E l l  IN VITHO
0 .002  mg/ml * • * * * 2 .0 0 .7 *
0 .0 2  fqg/ml * * • • * 3 .0 1 .2 •
0 .2  mg/ml * * * * * * 6 .0 66.7*
2 .0  mg/mi
E l l  IN VITHO -  TffiMINE RESCUE
* * * * * * •
0 .2  mg/ml THY h 
0 .2  ng/ml THY + FIT
« 1.5 0 .9 * — - — -
• - 15.0 9.1* • - 0.9 •
0 .02  mg/ml THY + FIT • * « * * 1 .0 - 50.0*
0.002 mg/ml THY + FU «
*90 -
*
100% o f
*
elem ents were
*
m issing
* 0 .9 *
£ Values expressed are  percentages of remaining d ig its .  
Cultures contained 0.02 mg/ml FU.
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variation from the values obtained for un treated  controls and generally areas tended 
to decrease with increasing dose.
Addition of thymine to the culture medium produced consistent dose-dependent 
results (Table 7). When 0.2 mg/ml thymine was added to  otherwise untreated  cultures, 
some cartilage anlagen showed enhanced growth (radius, ulna, carpals). When 0,2 
mg/ml thymine was added to  culture medium containing 0.02 mg/ml FU, the size of all 
cartilaginous bone models was increased with respect to  0,02 mg/ml FU limbs. Most 
areas were unchanged a t equimolar thymine concentration and were sometimes 
reduced a t a thymine concentration of 0.002 mg/ml. In no case did areas reach the 
size of untreated  controls.
The cartilage anlagen of G12 cultured hindlimbs (Table 8) displayed decreased 
areas a t  all doses of FU except for P-III whose area was a ffec ted  only a t  40 mg/kg. 
Generally, no difference was observed betw een treatm ents o f 10 and 20 mg/kg. 
Results for E l l  cultured hindtimbs of in u tero  trea ted  fetuses were not remarkable. 
The area of the ilium was increased a t 10 mg/kg, but was decreased significantly a t 
20 and 40 mg/kg. Phalanx III displayed decreased areas a f te r  all treatm ents. Other 
bones were basically unaffected. Hindlimb bones exposed to FU in vitro  were 
significantly decreased a t all doses, except for the fibula, which was decreased only 
a t the largest dose.
The enhancement of hindlimb bone area  by addition of 0.2 mg/ml thymine to the 
medium was more prominent than th a t described above for forelimbs (compare Table 7 
and Table 8). All bones except the fibula had increased area  measurements with 
respect to E l l  un treated  control hindlimbs. When thymine was coupled with FU a t 
equimolar or g rea ter concentrations, cartilage development was enhanced in a  dose- 
dependent manner when compared to  0.02 mg/ml FU cultures. Addition o f 0.002 mg/ml 
thymine generally had no a ffec t, although MT-1II was significantly decreased in size a t 
this dose.
TABLE 7  -  EPFBCTS OF FU OH THE AREA OP INDIVIDUAL BONE ANLAGEN OF CULTURED FGRELUfiS®
TREATUVT C m iP SCAPULA HINERUS RADIUS ULNA CARPALS MMII P P - I I I
E12 IN VIVO/IN V1TBO
U n tre a te d  
ID q g /k g  
2D q g /k g  
40 m g/kg
E t l  IN V1VO/IH VITO) 
U n tre a te d
10 fflg/kg 
20 m g/kg 
40 m g/kg
E l l  IN VITRO
0.002  ng /m l 
0.02  qg /m l 
0.2  qg/m l 
2.0  qg /m l
7 2 .0 9 ± 2 .2 8  
57 .0 1  * 2 .4 2 ' 
5 4 .8 3  ± 3 .1 9  
4 3 .2 2 ± 2 .4 5 e .d
2 4 .1 2 1  0 .9 2 _  
2 7 .1 3  ± 1.25, 
2 0 .6 5 ± 1 .2 0  
I B .14 ± 1 .4 6
e.d
1 2 .3 4 ± 0 .4 4 ^  ,  
9 .7 7 ± 0 .5 9 ° ’ j  
6 .3 0 ± 0 .3 3 °  
4 .4 8 ± 0 .3 4
5 1 .3 4 ± 1 .71  
4 6 .9 7  ± 1 .4 2  
4 9 .2 0 ± 1 .7 9
3 4 .6 4  *  1 .4 8 e .d
2 3 .1 6  ± 0 .5 3  
2 1 .7 8 *  1 .7 3  
2 1 .3 4 ±  1.15, 
1 7 .4 0 * 0 .8 0
1 0 .9 4  ± 0 .2 0 ,| 
1 1 .3 7 *  0.46, 
6 .8 0 ± 0 .2 3  
5 .3 0  ± 0 .2 3
e.d
2 0 .2 1 1  0 .4 7  
1 7 .8 4 1 0 .4 7 °  
1 7 .2 4 1  0 .6 5 °  
1 5 .8 4 1  0 .5 0
9 .5 1  
8.01 
8 .7 0 1 0 .3 1  
7 .2 2 1  0 .4 8 ’
: 0 .2 0  
; 0 .2 3 °
5 .0 0 1  0 .2 0 ^  
5 .3 2 1 0 .2 6 ,  
2 .4 4 1 0 .1 1  
1 .4 7 1  0 .1 3 '
e .d
e.d
2 7 .7 2  1 0 .6 5  
2 5 .0 5  * 0 .6 7 °  
2 4 .6 5  ± 0 .8 9  
1 5 .7 7  * 0 . 6 ie .d
1 1 .9 7 * 0 .3 0
1 1 .5 2 1 0 .3 5
9 .3 3 1 0 .4 9
7 .2 0 * 0 .5 5
;e .d
e .d
5 .6 9 1 0 .1 9  
4 .5 1  * 0 .2 5  
2 .4 5 1 0 .1 2  
1 .7 5 *  0 .1 6
C'rte .d
1 0 .IS  *  0 .2 9 .  
8 .4 4 1 0 .3 0 °  
7 .7 0  1 0 .3 1 °  
7 .1 7 1 0 .2 3
4 . 3 0 1 0 . 16„ 
3 .6 5 1 0 .1 3 °  
3 .6 7 1 0 .1 8 °  
3 .6 3 1 0 .2 6
1 .3 2 1  0 .0 6 °  
0 .9 6 1  0 .0 6 °  
0 .7 B ±  0 .1 0 °  
0 .5 1 1  0 .0 3
1 1 .1 1 1 0 .2 5 _  
1 0 .2 5 * 0 .2 4  
8 .5 0 1 0 .3 2  
7 .5 7 1 0 .2 5
ie.d
e .d
5 .1 9 * 0 .1 2  
4 .3 4 1 0 .1 8  
4 . 7 1 1 0 . 1 8 .  
4 .2 6 1 0 .3 0
3 .2 0 * 0 .1 1 °  
2 .8 2 1 0 .1 8  
1 .9 8 *  0 .1 3 ' 
1 .7 1 1  0 .1 4 °
le .d
4 .8 9 1 0 .1 8  
4 .7 7 1 0 .1 5
3 .4 2 1 0 .1 9  
2 .8 1 1 0 .1 7 e .d
1 .4 7 1 0 .0 6
1 .2 4 1 0 .0 6
1 .3 7 1 0 .1 7
1 .3 7 1 0 .1 7
0.6Si 
0 .6 1  i
o.or
0 .0 6
E l l  IN VITRO -  THfflflHE RESCUE
0 .2  mg/ml THV 
0 .2  qg /m l THV + 
0 .0 2  qg /m l THV + 
0 .0 0 2  ng /m l THV +
2 3 .2 9 1 0 .9 9  
1 5 .3 9 1  0 .5 9  
9 .5 1 1  0 .41  
6 .9 2 * 0 .4 1
,e .d ,e
e .d
e , d , e
2 4 .2 2 1  0 .6 6  
1 5 .3 8 *  0 .6 6  
1 1 .4 0 *  0 .3 4  
8 . 9 8 i  0 .4 2
fc .d .e
e .d
c . d . e
1 0 .1 5 1  0 .1 7  
8 . 3 9 i  0 .3 0
6.031  0 . 12.
4 .8 5 1  0 .2 2
,e .d ,e
'c .d .e
e .d
1 2 .9 9 *  0 .2 9  
8 .6 1 1 0 .3 4  
5 .0 3 *  0 .17 , 
5 .0 2 *  0 .2 3
c . d . e
e .d
e.d
4 .7 4 *  0 .1 5  
2 .5 2 1  0 .2 0
1 .4 6 i
0 ,9 3 1
0 .0 7
0 .0 7
,e ,d ,e
e . d . e
e ,d
5 .4 4 *  0 .17 , 
4 .2 9 1  0.17, 
3 .2 4 1  0 .1 1  
2 .3 6 ±  0 .1 4 '
e . d . e
e .d
e.d
1 .7 6 1  0.09 ,
0 . 86±
0 .6 0 ±
0.08'
0 .1 7
e . d . e
V a lu es  e x p re s s e d  a r e  mean ( |D *  x  1 0 ~ * ) l  SO.
C u l tu r e s  c o n ta in e d  0 .0 2  mg/ml FU.
V a lu es  a r e  s t a t i s t i c a l l y  d i f f e r e n t  f r a n  u n t r e a t e d  c o n t r o l s  (p  < 0 .0 5 ) .
d  V a lu es  a r e  s t a t i s t i c a l l y  d i f f e r e n t  from  p re c e d in g  d o se  (p  < “ - J 5 ) .
e  V alues a r e  s t a t i s t i c a l l y  d i f f e r e n t  from  c u l t u r e s  c o n ta in in g  0 .0 2  mg/ml FU (p  < 0 .0 5 ) .
Lft%o
TABLE 8 -  EFFECTS CT FU OH THE AREA OF INDIVIDUAL BONE AKLAGEH CF CULTURH) HINDLttBS®
IBEATKBtr O CU P ILIIM P M R TIB IA FIBULA TARSA1S MT- I I I  FI
E12 IN V IW /IN  VITRO
U n tr e a te d  
10 m g/kg 
20 n g /k g  
40 m g/kg
4 0 .8 9 1 1 .2 9 -  
2 8 .5 9 1 1 .1 3 °  
2 6 .8 2 s 1 .1 7 ' 
1 9 .4 2  + 1 .1 8 * , a
3 3 .2 6 *
2 6 .7 2 ±
2 6 .3 8 1
2 1 .5 6 ±
0 .7 2
0 .7 6 °
° . o £  a
0 .9 6
2 5 .6 6 1  
2 1 .B9 ± 
2 1 .4 5  ± 
1 4 .8 8 1
0 .5 S „  
0 .7 4 °  
° .S 7 °  d  
0 .7 9
1 0 .9 4 ± 
6 .3 2 1  
6 .5 0 1  
4 .3 1 *
0 .2 5 .
0 .3 7 °
°* 34e  a  
0 .5 5  1
1 8 .0 9 ±  0 .5 0 .  
1 4 .7 1 *  0 .7 0 °  
1 4 .5 3  * 0 .6 3 °  ,  
1 1 .9 2 *  0 . 9 0 ° '°
9 .7 6 *  
8 .4 7 *  
7 .2 9  + 
4 .2 3  +
0 .1 7  5 .1 5  + 1 
0 .1 8 .  3 .1 9 * 1  
0 . 2 5 ° ' j  3 .0 4 H  
0 .2 3  * 2 . 5 4 1 i
E l l  IN VIVD/IN VITHD
U n tre a te d  
10 o g /k g
20 n g /k g  
40  m g/kg
1 2 .1 7  ± 0 .7 7  
1 4 .2 5  1  0 .8 4 °  ,  
9 .6 6  ± 0 .7 6 °  
8 .0 1 1  0 .7 3
1 3 .5 9 ±  
1 1 .0 3 1  
1 2 .4 5  ± 
1 1 .9 4 1
0 .4 1
0 .7 9
0 .6 5
0 .6 1
1 1 .3 7 1  
1 0 .8 6 1  
9 .9 6  ± 
9 .1 0 1
0 .3 7
0 .3 2
0 .5 2
0 .6 1 °
2 .6 9 *
2 . 2 5 *
2 .3 8 *
2 .1 7 ±
0.11
0 .1 7
0 .3 7
0 .1 4
8 .0 1 *  0 .3 4  
7 .0 8 *  0 .3 4  
6 . 9 0 *  0 .5 0  
7 . 9 8 *  0 .7 3
3 .2 1  + 
3 .1 2  + 
3 .0 6 1  
2 .7 1  +
0 .1 5  1 .7 0 1  
0 .1 3  1 .2 5 1  
0 .2 5  1 .4 0 1  
0 .1 8  1 .0 8  +
E l l  IN VITRO
0.002  ng /m l 
0.02  ng /m l 
0 .2  Qg/ml 
2.0  mg/ml
4 .2 8  ± 0 .3 4 °  
3 .6 1 * 0 .2 8 °  
2 .4 8  ± 0 .1 6 °  
2.12  ± 0.20
8 .3 5 1  
7 .2 6 1  
5 .1 6 1  
4 .4 4  ±
0 .2 9 °  
0 .3 6 *  A 
0 ,2 4 °  
0 .3 6
8 .4 5  1 
7 .1 4  ± 
3 .7 6  ± 
3 .0 5  ±
0 .4 3 °
°* 41C d  0 .2 6 ° ’
0 .2 4 °
1 .5 2 *
1 .5 5 *
1 .8 4 *
0 .7 5 *
0 .1 5
0 .1 6
0 .1 9 ,.
0.22
4 .1 2 *  0 .2 9 *  
2 .3 7 *  0 .1 9 °  
2 .7 2 *  0 .2 1 °  
1 .8 0 +  0 .3 4 °
2.20  + 
2 .0 4 1  
2 .1 6 1  
1 .5 1  +
0 .1 7 °
0 .1 7 °
0 .3 0 °
0 .1 9 °
E l l  IN V11BO -  THYMINE RESCUE
0 .2  Qg/ml THY h  
0 .2  mg/mi THY + FUT 
0 .0 2  o g /m l THY + F1C 
0 .0 0 2  o g /m l THY + FIT
15 .9 3  ± 0 .4 7 °  „  .  
7 .5 0  1 0 .2 8 j ’ j ’ °  
5 . 2 1 ± 0 .1 9 ^ * 2  
2 .9 2 1 0 .1 6
1 8 .4 5 1
1 3 .8 5 1
1 0 .2 5 1
6 .5 5 1
0.33*1 .
0 . 20p * j
O - K ' d '
o . ib ° - d
1 3 .3 3  ± 
1 2 .2 6  ± 
10.01 1 
6 .5 3  ±
0 . 21°  ,  .  
0 . 2 9 ° ' j ' °
° - 19e ’d  0.20  ’
2 .9 0 *  
2 .6 2 1  
2 .3 6 1  
1 .7 0  ±
0.12
0. 12°
° * 13e  d  0 . 11° ’ °
8 .7 0 +  0 .1 8 °  „  .  
5 .9 2 *  0 .2 6 ° ’S 
3 .9 7 *  0 .0 9 ° * j*  
1 .9 1 +  0 .1 0  *
4 .9 3 1  
2 .6 2  + 
2 .3 0 1  
1 .2 4  +
0 . 12°  H „  2 .0 8  + 
0 .1 4 ° ’ 0 .5 1  + 
0 .0 9 °  d  
0 .0 7
•  2 - 4
j* V a lu e s  e x p re s s e d  a r e  mean Cps X  10 ) ± SD.
C u l tu r e s  c o n ta in e d  0 .0 2  ng /m l FU.
d  V a lu e s  a r e  s t a t i s t i c a l l y  d i f f e r e n t  from  u n t r e a t e d  c o n t r o l s  (p  < 0 .0 5 ) .
V a lu e s  a r e  s t a t i s t i c a l l y  d i f f e r e n t  frcm  p re c e d in g  d o s e  ( p  < 0 .0 5 ) .
V a lu e s  a r e  s t a t i s t i c a l l y  d i f f e r e n t  from  c u l t u r e s  c o n ta in in g  0 .0 2  Qg/ml FU (p  < 0 .0 5 ) .
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In addition to evaluating the size of bone anlagen, image analysis provided data 
regarding the shape of individual s truc tu res. Except for thymine rescue cultures, no 
consistent pattern  of change in forelimb shape was observed with FU treatm ent (Table 
9). Examination of ulna data, for example, indicates th a t a t some doses FU caused a 
rounding of the bone (increased value) with respect to a  previous dose (E12 in vivo/in 
v itro , 10 mg/kg) while a subsequent dose caused elongation (decreased value as with 
E12 in vivo/in v itro , 20 mg/kg). In thymine rescue cultures, the long bones and 
carpals exhibited dose dependent increases in shape facto r, but these changes did not 
represent returns toward the norm. The shape facto r of hindlimb long bones in E12 in 
vivo/in vitro  studies indicated a tendency toward rounding, reflecting the loss of 
length as a  result of FU exposure (Table 10). In o ther experiments FU had nonspecific 
e ffec ts .
The information obtained from tracings of individual bone anlagen and entire 
limbs was compiled to provide further insight Into the e ffec ts  of FU on growth and 
development of cultured limb buds. Total limb area  was significantly decreased a t all 
FU doses in E12 forelimbs (Table 11). The loss of size was reflected  in decreased 
values for both bone and so ft tissue. While the two tissues seemed similarly affected  
a t 10 and 40 mg/kg (soft tissue/bone ratios were unaffected) bone area showed 
g rea te r relative decrease a t 20 mg/kg (soft tissue/bone ra tio  increased.) The bones o f 
the paw were more affected  than the long bones as demonstrated by increased values 
of the long bone/paw ratio . For E l l  cultured limbs, only 40 mg/kg FU was effective 
a t reducing areas of to ta l limb, bone and so ft tissue. Bone anlagen displayed greater 
sensitivity than soft tissue reflective of increased incidence of missing elements. All 
doses displayed increased long bone/paw ratios. At 10 and 20 mg/kg, the differences 
were small but significant and seem strange in light of no noticeable changes in the 
to ta l bone area a t these doses. Changes in size of the  small paw bones may have
TABLE 9 -  EFFECTS OF FU ON THE SHAPE FACTOR OF INDIVIDUAL BCNE AN1A2H OF CULTURH) FORELISBS®
TREATJENT CXXJP SCAPULA HUERUS RADIUS ULNA CARPALS NC-III P P -11I
E l l  IN V1VO/IH VITHD 
U n tre a te d
10 mg/kg 
20 n g /k g  
40 m g/kg
£11 IN YIVO/1N V IT O
0 .S 3  t O . 01 
0 .5 2  ± 0 .0 1  
0 .S 4  ± 0 .0 1  
0 .5 4  ± 0 .0 1
0 .4 S  ± 0 .0 1  
0 .4 9  ± 0 .0 1  
0 .5 0  ± 0 .0 1  
0 .4 8  ± 0 .0 1
0 .4 4  ± 0 .0 1 „  
0 .5 0  ± 0 .0 1 °  
0 .4 9  ± 0 .0 1 °  
0 .4 7  ± 0 . 01C
0 .3 7  ± 0 .0 1 .  
0 .4 2  ± 0 .0 1 °  
0 .3 8  ± 0 .0 1 .  ,  
0 .4 3  ± 0 .0 1  *
0 ,2 9 *
0 .3 3 1
0.01.
0 . 01*
0.35± o .o r  
0.37* 0.01°
0 .5 8  ± 0 .0 1 .  
O.E4 ± 0 .0 1
o .e i  ± 0.01 
0.60  ± 0.01
0 .7 0  ± 0 .0 1  
0 .7 6  ± 0 . 01°  
0 .7 3  ± O .O lH 
0 .6 7  ± 0 .0 2
U n tre a te d  
10 m g/kg 
20 m g/kg 
40 n g /k g
E l l  IN VITRO
0.002 Kg/ml 
0.02 cg/ml 
0.2 ng/ml 
2.0 ng/mt
0 .4 3  ± 0 .0 1  
0 .4 4  ± 0 .0 1  
0 .4 2  ± 0 .0 1  
0 .4 5  ± 0 .0 1
0 .4 4 ±  0 .0 1  
0 .4 4 ± 0 .0 1  
0 .4 5 ± 0 .0 1  
0 .4 B *  0 .0 2
0 .4 5  ± 0 .0 1  
0 .4 3 * 0 .0 1  
0 .4 4  ± 0 .0 1  
0 .4 4  ± 0 .0 1
0 .4 5 ±  0 .0 1  
0 .4 6 *  0 .0 1 .  
0.42  ± o.o i°,a
Q .40±  0 .0 1 °
0 .4 8  ± 0 .0 1  
0 .4 5 * 0 .0 1  
0 .4 5 * 0 .0 1  
0 .4G  ± 0 .0 1
o .53* o .o r  
0. 52± 0 .o r  
0. 53± o .o r  
0 .4 7 *  0 .0 1 °
0 .4 0 * 0 .0 1  
0 .3 8 * 0 .0 1  
0 .3 7  ± 0 .0 1  
0 .3 8 * 0 .0 1
0 .4 3 *  o .o r  
0 .4 0 *  o .o r  ,n u .  n ntc*°0 .4 4 *  0 .0 1  
0 .3 6 ± o .a i 'e.d
0 .1 6 ±  0.01 
0 .1S± 0.01 
0 .1 7 *  0 .0 1  
0 .2 3 *  0 .0 3
0 .3 7 ±  0 .0 2  
0 .5 4 ±  0 .0 4  
0 .5 4 ±  0 .0 5  
0 .6 4 ±  0 .0 4
e .d
'e
c,d
0 .5 8 * 0 .0 1
0 .5 3 * 0 .0 1
0 .5 5 * 0 .0 1
0 .4 2 * 0 .0 1 e .d
0 .5 4 * 0 .1 0  
0 .4 4  ± 0 .0 2 ' 
1 .4 5 *  0. 01)5 
0 .4 2 ±  0 .0 1
le .d
0.68  ± 0 .02 
0.58 ±0, 01° 
0 .5 6  ± 0 .0 1 °  
0 .4 9 * 0 .0 4 °
0 .7 0  i 
0 .7 4  i
0.02
0.01
E l l  IN VITRO -  TOfflUNE RESCUE
0 .2  ng /m l THY 
0 .2  mg/ml THY + 
0 .0 2  mg/ml THY + 
0 .0 0 2  mg/ml THY +
0 .4 7 ± 0 .0 1  
0 .5 3 ±  0 .0 1  
0 .5 4 ±  0 .0 1 ^  
0 .5 6 ±  0 .0 1
e . d 0 .4 8 *  0 .4 7  ± 
0 .5 1 :  
0 .5 8 ;
0.01
0.01
0.01
0.01
e.d
e.d
o.S4 * o .o r  
0 .5 4 *  0 .0 1  
0 .5 7 ;  O.OI 
0 .6 1 ;  0.01
e .d
e .d
0 .4 4 ± o .o r  
0 .4 5 *  0 .0 1  
0 .4 S ±  0 .0 1  
0 .5 2 ±  0 .0 1
e .d
e .d
0 ,2 7 *  0 .0 1
0 .4 3 ±
0 .5 6 ±
0.02
0 .0 3
;c.d
;c .d
0 .7 1 ±  0 .0 4 e.d
0 .6 1 *
0 .5 9 *
0 .6 2 *
0 .6 7 *
0.01
0.01
0.02
0.02;e,d
0 .7 3 ±  0 .0 1  
0 .7 5 ±  0 .0 1  
0 .8 2 1
. V a lu es  e x p re s s e d  a r e  m eans ± SO.
“  C u l tu r e s  c o n ta in e d  0 .0 2  o g /m l FU.
. V a lu e s  a r e  s t a t i s t i c a l l y  d i f f e r e n t  from  u n t r e a t e d  c o n t r o l s  (p  < 0 .0 5 ) .
V a lu e s  a r e  s t a t i s t i c a l l y  d i f f e r e n t  from  p re c e d in g  d o se  (p  < 0 .0 5 ) .
V a lu e s  a r e  s t a t i s t i c a l l y  d i f f e r e n t  from  c u l t u r e s  c o n ta in in g  0 .0 2  mg/ml FU ( p  < 0 .0 5 ) ,
TABLE ID -  EFFECTS OP FU OH THE SHAPE FACTCR OF INDIVIDUAL BCWE ANL/GEN OF CULTUHH) HINDLIMS®
TREATAENT GROUP 1LIIW m m t i b i a FIB1UIA TARSALS M T -III P P - I I I
E l2 IH VIVD/IH VITRO
U n tre a te d  
10 mg/kg 
ID a g /k g  
40 m g/kg
E l l  IH V 1 W IH  VITRO
U n tre a te d  
10 n g /k g  
20 n g /k g  
40 t tg /k g
E l l  IH VITHO
0.002  ng /m l 
0.02  ng /m l 
0.2  mg/ml 
2.0  c g f o l
0 .4 0  ± 0 .0 1 -
0 .4 7 :  
0 .4 4  :
0.01
0.01
0 .5 7  ± 0 .0 2
0 .4 1  ± 0 .0 1  
0 .3 2  ± 0 .0 1 .  
0 .3 7  ± 0 .0 1  
0 .5 0  ± 0 .0 2 c .d
0 .5 4  ± 0 .0 2 ^  
0 .5 8  ± 0 .0 2  
0 .6 7  ± 0 .0 3Ic.d
0 .4 8  ± 0 . 01,
0 .5 2  : 
0 .5 2 :
o.oi;
0.01
0 .5 8  ± 0 .0 1
C .d
0 .4 4  ± 0 .0 1  
0 .4 9  * 0 .0 2  
0 .4 0  ± 0 .0 1  
0 .5 4  ± £ .0 1
c .d
0 . 6 1 ± 0 ,0 4
0 .5 4 1 0 .0 1  
0 .6 0 1 0 .0 1  
0 .5 6 ±  o .o r  
0 .5 8  - 0 .0 1
e . d
0 ,4 9  ± 0 .0 1
0 .5 5 :
0 .5 4 :
0 .5 5  * 0 . 0 l v
o.oi;
o .o r
0 .5 8  * 0 .0 1  
0 .5 7 *  0 .0 1  
0 .5 9  ± 0 .0 1  
0 .6 1  ± 0.02
0 .4 8 *  o .o r  
0 .5 8 *  0 .0 1  
0 .5 4 *  0 .0 1  
0 . 5 5 ± 0 .0 2
0 .5 2  ± 0 .0 1 .
O.fiO: 
0 .5 9  :
0-02;
0.01
0 .7 1  * 0 .0 2
0 .5 8 * 0 .0 1  
0 .6 2 1 0 .0 1  
0 .6 2 1 0 .0 2  
0 .6 0  ± 0.01
0 ,5 6 * 0 .0 3  
0 .6 3 1 0 .0 3  
0 .6 0 * 0 .0 5  
0 .6 1  * 0.01
c .d
0 .2 8  ± 0.01 
0 .2 9 * 0 .0 1  
0 .2 7  1 0 .0 1  
0 .4 0 * 0 .0 3 'c .d
0. 1610.01  
0 .2 3 1 0 .0 1  
0 .2 4  ± 0 .0 1  
0 ,2 9  ± 0 .0 3
0 .3 9 1 0 .0 3  
0 .5 9 1 0 .0 3 ' 
0 .4 3 * 0 .0 3  
0 .3 9  ± 0 .0 7 ^
C .d
c .d
0 .5 6 * 0 .0 1
0 .5 7 1 0 .0 1
0 .5 6 ± 0 .0 1
0 .6 8 1 0 .0 2
0 .5 9 ± 0 .0 1  
0 .5 6 ± 0 .0 1  
0 .5 8  ± 0 .0 2 .  A 
0 ,6 9 ± 0 .0 2  '
0 .6 4 ±  0 .0 2  
0 .6 0 1  0.02 
0 .5 9 1  0 .0 2  
0 .5 1 1  0 .0 2
0 .6 4 1 0 .0 1
0 .6 9 1 0 .0 1
0.6810.01
0 .7 0 1 0 .0 3
0 .7 2  ± 0 .0 1  
0 .6 6  ± 0 .02  
0 .6 5 1 0 .0 2  
0 .7 2 1 0 .0 3
E l l  IH VITRO -  T1KM1NE RESCUE
0 .2  n g /m l THY 
0 .2  ng /m l THY + 
0 .0 2  n g /m l THY A 
0 .0 0 2  n g /m l THY +
0 .4 9 :
0 .5 5 :
0.01
0.02
0 .5 0 ±  0 .0 1  
0 .6 5 1 0 .0 2 '
c .d
c .d
c .d
O.SOl 0.01 
0 ,6 1 1 0. 0l'
0 .5 8 :
0 .6 7 :
0.01
0.01
c .d
c .d
c .d
0.66* o .o r
D .56± 0 .0 1 °  
0 . 5 5 ;  0 .0 1 °
0 .6 0  t  0.01
0.70* o .o r
0 .5 8  ± 0 .0 1  
0 .5 6 1 0 .0 1  
0 .6 1  ± 0.02
0.251 o .o r  ,  
0 . 4 7 ± 0 . 0 4 ° r  
0.40 ± o .o r ' j
0 .5 5  * 0 .0 2  ’
0 .6 8 1  o .o r  
O.SB± 0 .0 1  
0 .6 S ±  O.Ol' 
0 .7 2 ±  O.Ol'
C .d
e .d
0 .7 8 1  0 .0 1  
0 .7 7 1  0 .0 5
. V a lu e s  e x p re s s e d  a r e  m eans 1 5 0 .
C u l tu r e s  c o n ta in e d  0 .0 2  n g /m l FU.
. V a lu e s  a r e  s t a t i s t i c a l l y  d i f f e r e n t  from  u n t r e a t e d  c o n t r o l s  (p  < 0 .0 5 ) .
V a lu es  a r e  s t a t i s t i c a l l y  d i f f e r e n t  f r a n  p re c e d in g  d o se  (p  < 0 .0 5 ) ,
V a lu es  a r e  s t a t i s t i c a l l y  d i f f e r e n t  from  c u l t u r e s  c o n ta in in g  0 .0 2  a g /m l FU tp  < 0 .0 5 ) .
TABLE 11 -  EFFECT OF FU OK PAKttEIERS OF CBCWIH AND DEVELORiENT IN CULTURED FCRELLSBS8
SOFT TISSU E/ LONS B M E /
TOEAIlBrr Q p g  TOTAL L B B  AREA TOTAL BGKE AREA SOFT TISSUE AREA POKE RATIO PAW RATIO
E H  IN VIVO/IN V1THO
U n tr e a te d  4 0 4 .7 1  * 5 .8 9 .  2 4 9 .8 3  * 4 . 9 8 .  1 5 5 .0 8  ± 3 .4 8  0 .6 3  * 0 .0 2  2 .1 9  * 0 .0 4
10 m g/kg  3 4 7 .9 7  ± 8 .0 6 °  2 1 3 .5 6  ± 5 .0 8 °  d  1 3 4 .4 1  ± 4 .6 0 °  0 .6 4  * 0 . 0 2 .  2 .2 1  * 0 ,0 4 .  a
20 n g /k g  3 3 1 .0 6  ± 9 .1 2 °  j  1 9 5 .6 9  ± S .9 6 ° * d  1 3 5 .3 7  ± 4 .3 3 °  H 0 .7 1  ± 0 .0 2 °  3 .2 0  ± 0 . 1 6 ° 'd
40 n g /k g  2 3 3 .9 S  ± 8 .5 3 ° *  1 4 2 .2 6  * 4 .9 2 ° *  9 1 .6 8  ± 4 .2 6  * 0 .6 4  * 0 .0 2  4 .0 5  ± 0 .2 9  *
E l l  IN VITO/IN VITRO
U n tr e a te d  1 9 4 .7 7  ± 3 .5 7  8 9 .2 1  ± 1 .5 5  1 0 5 .5 6  ± 2 .7 5  1 .2 5  ± 0 .0 6  2 .8 1  ± 0 . 1 7 .
10 n g /k g  1 9 4 .6 9  ± 4 .8 2  8 7 .4 9  ± 3 .1 2  1 0 7 .2 1  ± 2 .9 3  1 .3 1  * 0 .0 9  3 .5 8  * 0 .1 1 °
20 n g /k g  1 9 9 .7 5  ± 5 .9 1  .  8 6 .3 8  ± 3 .4 5  a  1 1 2 .3 7  ± 3 .5 5  . 1 .4 2  ± 0 . 1 2 .  3 .6 2  ± 0 .2 4
40 n g /k g  1 4 8 .1 8  ± 5 .7 5  * 5 9 .7 8  ± 3 .9 6  * 8 8 .4 0  ± 2 .7 3 ° * “  1 .9 0  + 0 .2 0 °  7 . 7 3 + 1 . 4 1 °
E l l  IN VITRO
0 .0 0 2  n g /m l 1 2 5 .4 5  ± 3 .4 0 °  d  4 2 .6 1  ± 0 .8 6 °  8 2 .8 4  ± 3 .2 8 °  2 .0 3  ± 0 .1 4 °  4 .2 1  ± 0 .2 3 °  d
0 .0 2  Bg/m l 1 0 1 .0 0  ± 4 .3 1 ° * d  3 6 .9 7  ± 1 .7 5 °  rt 6 4 .0 3 ± 3 .7 4 d * 1 . 9 7 ± 0 . 1 2 °  . 5 .8 9 ± 0 .4 8 ° * “
0 .2  n g /m l 1 2 0 .6 4  ± 4 . I6 °* d  2 0 .7 9 ± 0 .9 3 ° *  9 9 . 8 S ± 4 . 1 2 ° ,  5 .4 4  ± 0 .4 1 ° ’d  7 .3 2 * 1 . 0 8 °
2 .0  mg/m l 1 0 2 .1 2  ± 3 .3 9 ° *  1 4 .2 2  ± 1 .0 6 °  8 7 .9 0  ± 2 . 7 1 ° '°  8 .2 8  + 0 .8 9 ° *  6 .8 5  + 1 .3 2
E l l  IB VITRO -  THOU HE RESCUE
0 .2  n g /m l TOT h  1 8 5 .1 6  ± 4 . 08_ ,  9 6 .9 6  -* 2 .0 2 °  ,  8 8 .1 9 ± 2 .5 6 °  0 .9 2  + 0 .0 2 °  2 . 8 3 ± 0 . 1 4 „ d
0 .2  n g /m t TOT + F IE  1 2 0 .8 8  ± 3.32°**}’°  6 2 .8 0 ± 2 .4 3 ° ’d *° 5 8 .0 8  ± 1 .7 5 °  „  1 .0 7  + 0 .1 3 °  3 . 6 5 + 0 . 2 1 ° ’“ *°
0 .0 2  n g /m l TOT + F i t  8 1 .7 9  ± 1 .6 8 ° ’“ * '  4 2 .1 2 = 1 .1 5 ° * “ *° 3 9 .6 7  ± 1 .0 8 ° * “ ’ 1 .0 9  + 0 .0 4 °  3 .9 2 +  0 .2 4 °*
0 .0 0 2  m g/m l TOIf + F IT  6 8 .6 2 ±  2 .6 8  * *° 3 0 .7 5  :  1 .4 7 °*  *° 3 7 .8 7 ± 2 .4 1 ° *  1 .4 6 ± 0 .1 3 °  6 .7 8 + 0 .9 2
a  2 - 4b  V a lu e s  e x p r e s s e d  a r e  m ean ( |tn  x  10 ) ±
C u l t u r e s  c o n ta in e d  0 .0 2  mg/ml FU.
d  V a lu e s  a r e  s t a t i s t i c a l l y  d i f f e r e n t  from
V a lu e s  a r e  s t a t i s t i c a l l y  d i f f e r e n t  frcm
V a lu e s  a r e  s t a t i s t i c a l l y  d i f f e r e n t  from
SD.
u n t r e a t e d  c o n t r o l s  ( p  < 0 .0 5 ) .
p r e c e d in g  d o s e  (p  < 0 .0 5 ) .
c u l t u r e s  c o n t a i n i n g  0 .0 2  n g /m l FU ( p  < 0 .0 5 ) .
TABLE 12 -  EFFECT OF FU CN PARA1KIERS OF C3UVIH AND DEVELUWOT IN CULTURED HINDU UVBS*
SOFT TISSUE/ LONG BONE/
TREAHBfT O O P P  TOTAL L ftB  AREA TOTAL BONE AREA SCFT TISSUE AREA BONE RATIO PAW RATIO
E l2 IN V1TO/1H VITBO
U n tr e a te d  3 4 9 .0 2 * 5 .6 5 „  1 6 8 .8 0 * 3 .1 1 , .  1 6 0 .2 2 *  3 .7 5 .  0 .8 5 *  0 . 0 2 .  1 .4 3  *  0 .0 3
lO B g /k g  2 8 1 .5 5 * 5 .01„ 1 3 9 .1 5 * 2 .8 0 .  1 4 2 .4 0 *  4 .1 1 .  1 .0 4 *  0.04®  1 .5 1  * 0 .0 4 „  *
20 n g /k g  2 8 6 .3 5 * 6 .1 8 ®  1 4 0 .1 6 * 3 .7 6 ® *  1 4 6 .1 8 * 4 .1 5 ®  1 .0 7 *  0.04®  H 1 .9 6  * 0.07® '®
40 n g /k g  1 7 1 .8 1 * 6 .9 5 ® '®  7 9 .0 4 * 2 .9 5 ® ' 9 2 .7 7  *  5.81®*® 1 .2 5 *  0 .0 9 ® '°  3 .6 2  * 0.24®*
E l l  IN VIVO/IN V IT O
U n tr e a te d  1 3 8 .2 2 * 3 .4 1  6 0 .2 0 *  1 .6 1  7 8 .0 2 *  2 .6 0  1 .4 0 *  0 .1 4  2 .0 9  *  0 .0 9
10 n g /k g  1 4 2 .1 6 * 4 .2 0 .  *  5 6 . 5 4 * 2 . 5 4 .  d  8 5 .6 2 *  2 .2 2  1 .6 3 * 0 .1 1  2 . 3 2 * 0 . 1 2 .
20 n g /k g  1 2 7 .4 5 *  5 .0 7 ® '.  4 8 .7 2 * 3 .2 4 ® ’"  7 8 .7 2 *  2 .7 8  * 1 .9 1 *  0 .1 3  3 .7 1  *  0.38®
40 n g /k g  1 0 7 .4 6 *  4.60®*“  3 9 .6 8 * 3 .1 5 ® '"  6 7 .7 9 *  2 .93® ’ 3 .2 5 *  0 .5 7  6 .5 6 *  1 .6 2
E l l  IN VITRO
0 .0 0 2  n g /m l 9 3 .9 9 *  3.79®  3 0 .1 0 *  1 .2 6 ® *  6 3 .8 9 *  3.63®  2 . 3 1 * 0 . 1 9 . *  3 . 0 7 * 0 . 1 8 ® .
0 .0 2  mg/ml 8 3 .4 8 *  2 . 8 5 ® .  2 0 .8 9 *  1.66®** 6 2 .5 9 ;  3.43®  *  7 .9 4 *  1 .8 7 ® '*  4 .8 2 *  0 .3 7 ® '
0 .2  ng /m l 1 0 6 .0 1 *  2 .7 4 ® ' 1 2 .4 8 * ; 0 .97® ’°  9 4 .8 1 *  2 .7 7 ® '“  1 0 .5 2 *  1 .2 1 ® ' 3 .9 1 * 0 ,5 0 ®
2 .0  mg/ml 9 3 .3 3 *  2.73® 8 .4 1 * 0 .9 7 ®  8 5 .9 4 *  2 .7 3  2 1 .5 6 *  3 .0 9  4 .5 4 *  1.06®
E l l  IN VITHO -  THMMME RESCUE
0 .2  m g/n l THY h  1 7 3 .9 7 *  2 . 4 2 ® * .  7 8 .9 3 *  1 . 0 3 ® * .  9 S .0 4 *  1 .8 7 *  .  1 .2 1 *  0 .0 4 .  1 .8 6 *  0 . 0 3 . * .
0 .2  n g /m l TOY + EUt 1 1 9 .5 7 *  3 .0 2 ® '“ '® 4 7 .2 1 *  1 .0 9 ® '* '®  7 2 .3 6 *  2 . 4 5 ° ' * .  1 .6 1 * 0 .1 2 ®  3 .5 0 *  0 .1 4 ® '* ’®
0 .0 2  n g /m l THV +  FU? 7 8 .2 8 *  2 .30® ’°  3 6 .9 0 *  0 .71® ’° '®  4 1 .3 8 *  2 .1 3 ® '“ *® 1 .1 4 * 0 .0 8 ®  3 .1 3 *  0 .0 7 ® '* '®
0 .0 0 2  n g /m l TOY + FIT  5 2 .6 9 *  1.70® ’°*® 2 1 .9 9 *  0 .70® *° 3 0 .7 0 *  1.28® ’“ *® 1 .4 3 *  0.11®  4 .3 3 *  0 .21® ’°
a  2 - 4r  V a lu es  e x p re s s e d  a r e  mean ( tin  x 10 > * SO,
C u l tu r e s  c o n ta in e d  0 .0 2  n g /m l FU.
*  V a lu e s  a r e  s t a t i s t i c a l l y  d i f f e r e n t  from  u n t r e a t e d  c o n t r o l s  (p  < 0 .0 5 ) .
V a lu e s  a r e  s t a t i s t i c a l l y  d i f f e r e n t  from  p re c e d in g  d o se  (p  < 0 .0 5 ) .
V a lu e s  a r e  s t a t i s t i c a l l y  d i f f e r e n t  from  c u tu r e s  c o n ta in in g  0 .0 2  n g /m l FU (p  < 0 .0 5 ) .
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been more noticeable in comparison to only the long bones but may have been masked 
as a component of a much larger mass.
E l l  in vitro  forelimbs displayed widespread effects; all area  values were 
decreased compared to  untreated  controls. One exception was the soft tissue area a t 
0.2 mg/ml. The seeming high value resulted from drastic  reduction of bone area 
coupled to  moderate reduction of limb size. Soft tissue/bone ratios increased with 
increasing dose implying predominant Involvement of the cartilaginous elem ents. 
Increased long bone/paw ratios fu rther suggested th a t the bony elem ents most 
affected  were those of the paw. Long bone components of cultured forelimbs were 
rarely absent (Table 13) but absence of the carpals (Table 13) and digits (Table 3) was 
dose-dependent in E l l  in vitro studies.
Thymine added to untreated  cultures enhanced cartilage development but not 
to ta l limb growth (Table 11). Similarly, addition of 0.2 or 0.02 mg/ml thymine to 
cultures also trea ted  with FU resulted in enhanced cartilage development but growth 
of the to ta l limb was improved only a t the higher thymine dose and was actually 
decreased a t  0.02 mg/ml thymine compared to  cultures with FU only. The improved 
cartilage development favored paw elem ents as long bone/paw ratios decreased, 
moving toward values for un treated  controls. When 0.002 mg/ml thymine was added, 
limb, bone and so ft tissue areas were decreased even more than with 0.02 mg/ml FU 
alone. Bones of the paw were, once again, a ffec ted  more than long bones.
Hindlimb effec ts  resembled the results described for forelimbs (Table 12). With 
most treatm ent regimens FU treatm ent resulted in dose-dependent decreased areas for 
to ta l limb, bone and so ft tissue. C artilage was more affected  than soft tissue as 
dem onstrated by increased soft tissue/bone ratios. The large increases seen in E l l  in 
vitro ra tios re flec t the to ta l loss of many limb components (Tables 4 and 14). Paw 
elem ents displayed g rea te r e ffec ts  than long bones. The deleterious nature of 0.02 
mg/ml FU on cartilage development was improved by equimolar or g rea ter
CM
r-»
TABLE 13 -  INCIDENCE OF MISSING COMPONENTS IN CULTURED FORELIMBS8
Seapula Humerus Radius Ulna C arpals
E12 in v ivo/in  v itro  
Untreated . _
10 mg/kg - - - - -
20 nqg/kg - - - - -
40 mg/kg — - — —
E ll in v ivo/in  v itro  
Untreated
10 mg/kg - - - - -
20 mg/kg - - - - -
40 mg/kg — — — 2 20
E ll in v itro
0.002 mg/ml 4
0.02 mg/ml - - - - 14
0.2 mg/ml - - - - 69
2.0 mg/ml — 2 16 18 76
E ll in v itro . Thymine Rescue 
0.2 mg/ml Thy h 
0.2 mg/ml Thy + FUT 
0.02 mg/ml Thy + FUT
- - - - -
- - - - 4
0.002 mg .ml Thy + FU - - - - 16
A
b Values expressed  a re  pe rcen tag es  o f  n = 49. 
C u ltu re s  con tained  0.02 mg/ml FU.
TABLE 14 -  INCIDENCE CP MISSING COMPONENTS IN CULTURED HlNDLHffiS*
Iliu m  Femur
E12 in  v iv o /in  v i t r o  
U ntreated  
10 mg/kg 
20 mg/kg 
40 mg/kg
E l l  in  v iv o /in  v i t r o  
U ntreated  
10 mg/kg 
20 mg/kg
40 mg/kg 2 2
E l l  in  v i t r o
0 .002  mg/ml 
0 .02  mg/ml
0 .2  mg/ml 6 12
2 .0  mg/ml 10 14
E l l  in  v i t r o , Thymine Rescue
0 .2  mg/ml Thy . -  -
0 .2  mg/ml Thy + FUT
0.02 mg/ml Thy + FIT
0.002 mg.ml Thy + FU
b Values expressed  a re  pe rcen tag es  o f  n = 49. 
O il tu r e s  con tained  0 .02 mg/ml FU.
T ibia
4
14
24
49
F ib u la T a rsa ls
2
6
20
4
12
35
2
29
47
57
85
96
2
31
67
84
14
74
concentrations of thymine but to ta l limb area was aided only a t  the higher dose. This 
enhanced cartilage formation aided in reducing the elevated so ft tissue/bone ratios. 
Also, the cartilage improvement favored paw elem ents as the long bone/paw ratios of 
thymine rescue cultures decreased, approaching the value of controls.
Biochemical E ffects
Total DNA and protein content of E l l  cultured limbs trea ted  with FU in vivo or 
In vitro was examined a t  initiation (Oh) and term ination (72h) o f the culture period. 
Some treatm ent groups were also measured a t  36h (E l l  in vivo/in vitro -  20 mg/kg,
E l l  in v itro  -  0.02 and 0.2 mg/ml).
All FU treatm ents produced decreased DNA content per forelimb (Table 15). 
Values obtained a t 36h were depressed compared to identical studies a t Oh. This trend 
continued to  72h in all groups except untreated  controls. In the la tte r , losses 
incurred during the initial 36h were subsequently recovered. In untreated  hindlimbs 
(Table 16), DNA content did not vary a t the times sampled. Similar observations were 
made in hindlimbs trea ted  in vivo with 20 mg/kg FU although the measurements 
reported for all trea ted  limbs were substantially reduced compared to  similarly timed 
controls. Hindlimbs exposed in vitro exhibited progressive cell loss as indicated by 
greatly  reduced DNA.
Changes in the to ta l protein content of forelimbs mimicked the a lterations in 
DNA (Table 17). All values of trea ted  limbs were decreased compared to timed 
controls. Initial (Oh -  36h) decreases for untreated controls were reversed by 72h but 
values for trea ted  limbs did not recover by the end of culture. Untreated hindlimbs 
exhibited a  sharp decline in measured protein between Oh and 36h and a  further 
decline by 72h (Table 18). Protein content of all trea ted  limbs was substantially 
reduced in a dose dependent manner compared to  timed controls, and within a given 
treatm ent group values were consistently decreased with increasing time in culture.
TABLE 15 -  EFFECT OF FU ON DNA CONTENT OF E ll  CULTURED BQRELIMBSa
_________________Hours in  c u ltu re _______________________  X change. 36h -  72h
Oh 36h 72h
U ntrea ted  12.87 ± 0.89 8 .58 ± 0.83 11.74 ± 1.47 +37
In v iv o :
10 mg/kg 9.91 ± 0.69b -  8 .04 + 0.74b
(77)d ( 68 )
20 ng/kg  8.22 ± 0.38b,C 6 .62 ± 0.45b 4 .85 + 0.49b,C -27
(64) (77) (41)
40 mg/kg 5.29 t  1 .53b,C -  2.55 + 0.77b,C
(41) (22)
In v i t r o :
0.002 mg/ml •  -  4 .08  ± 1.03b
(35)
0.02 mg/ml * 6.77 ± 0.33b 2.99 ± 0.45b,C -56
(79) (25)
± 0.97b,C 2.09 ± (
(57) (18)
0 .2  ng/ml * 4 .92 0.35b -58
b V alues expressed  a re  mean (pg) ± SD.
Values a re  s t a t i s t i c a l l y  d i f f e r e n t  from u n tre a te d  c o n tro ls  (p < 0 .0 5 ) . 
j  Values a re  s t a t i s t i c a l l y  d i f f e r e n t  from preced ing  dose (p < 0 .0 5 ) . 
Values in  ( ) in d ic a te  % o f  u n tre a te d  c o n tro ls .
TABLE 16 -  EFFECT OF FU ON DNA CONTENT OF E ll  CULTURED HINDLBBS®
_____________Hours in  c u ltu re ________________________________  96 change, 36h -  72h
Oh 36h 72h
U ntrea ted  10.52 ± 0 .52  9 .77  ± 0.98 11.68 ± 1 .05 +20
In v iv o :
10 mg/kg 8.67 ± 0 .48b -  8.05 ± 0.54b
(82)d (69)
20 mg/kg 6 .98  ± 0.49b ,C ' 6 .24  ± 1.24b 6 .08 ± 0.61b,C -3
( 66 ) (64) (53)
40 mg/kg 5.06 ± 1.09b,C -  4 .09  ± 0.83b,C
(48) (35)
In  v i t r o :
0.002 mg/ml * -  2 .54  ± 0.11b
(22)
0.02 mg/ml * 4 .94  ± 0 .48b 1.83 ± 0 .28b,C -63
(51) (16)
I ± 0 .42b,C 1 .34  + 0.
(35) (11)
0 .2  mg/ml * 3.40 .32b -61
£
^ Values expressed  a re  mean (pg) ± SD.
c  Values a re  s t a t i s t i c a l l y  d i f f e r e n t  from u n tre a te d  c o n tro ls  (p  < 0 .0 5 ) . 
d Values a re  s t a t i s t i c a l l y  d i f f e r e n t  from p reced ing  dose (p  < 0 .0 5 ) . 
Values in  ( ) in d ic a te  96 o f  u n tre a te d  c o n tro ls .
TABLE 17 -  EFFECT OF FU ON PROTEIN CONTENT OF E ll  CULTURED FQRELIMBS*
Hours in  c u ltu re  % change, 36h-72h
Oh 36h 72h
U ntrea ted  139.77 ± 7 .54  91.44 ± 11.55 123.88 ± 10.29 +35
In v iv o :
10 mg/kg 116.89 ± 6 .43b -  68.90 ± 9.24b
(84 )d (56)
20 mg/kg 99.32 ± 6 .17b,C 59.25 ± 8 .93b 44.57 ± 7 .22b ,e  -25
(71) (65) (36)
40 mg/kg 80.45 ±10.28b,C -  23.25 ± 8.49b,C
(58) (19)
In  v i t r o :
0.002 mg/ml * -  38.70 ± 5.36b
(31)
0 .02  mg/ml * 47.30 ± 9 .58b 24.94 i  3.70b,C -47
(52) (20)
0 .2  mg/ml * 18.06 ± 7 .81b,C 15.01 ± 4.23b,C -17
( 20) (12) I
?  Values expressed  a re  mean (pg) ± SD.
Values a re  s t a t i s t i c a l l y  d i f f e r e n t  from u n tre a te d  c o n tro ls  (p  < 0 .0 5 ) .
.  Values a re  s t a t i s t i c a l l y  d i f f e r e n t  from preced ing  dose (p < 0 .0 5 ) .
Values in  ( ) in d ic a te  % o f u n tre a te d  c o n tro ls .
TABLE 18 -  EFFECT OF FU ON PROTEIN CONTENT OF E ll  CULTURED HINDLINBS*
_________________ Hours in  c u l tu re _______________________  % change, 36h -  72h
Oh 36h 72h
U ntrea ted  128.71 ± 8 .12 84.31 ± 3 .87  71.58 ± 4 .99  -15
In v iv o :
10 mg/kg 104.07 ± 3 .58b -  42.98 ± 6.32b
(81)d (60)
20 ng /kg  83.79 + 8 .67b,C 56.31 ± 6.96b 31.68 ± 4.50b,C -44
(65) (67) (44)
40 mg/kg 56.82 ± 8.36b,C -  26.94 ± 3.38b ,e
(44) (38)
In  v i t r o :
0.002 ng/ml « -  26.40 ± 3 .48b
(37)
0.02 ng/ml •  46.91 ± 2.37b 16.88 ± 4 .05b ,e  -64
(56) (24)
0 .2  ng/ml * 15.85 ± 8 .35b,C 11.36 ± 2 .36b,C -28
(19) (16)
£
b Values expressed are  mean (pg) ± SD.
e Values are  s ta t i s t i c a l ly  d iffe ren t from untreated contro ls (p < 0.05). 
d Values are  s t a t i s t i c a l ly  d iffe ren t from preceding dose (p < 0.05). 
Values in ( ) indicate % of untreated con tro ls.
CHAPTER 4 
DISCUSSION
Whole animal studies to examine the teratogenic e ffec ts  of FU administered 
on E l l  displayed a  wide spectrum of e ffec ts  in E l7 offspring: micrognathia,
ocular/ auricular deformities, omphalocoele, exencephaly, c le ft palate, skeletal 
defects, decreased fe ta l wet weight and increased em bryolethality. While most 
defects were present only following treatm ent with 40 mg/kg FU, skeletal defects 
of the limbs (and most noteably of the paws) dem onstrated dose-dependent 
responses. This is not surprising since the stage selected for treatm ent (E ll)  is 
c ritica l in paw development. Knudsen and Kochhar found th a t adm inistration of 
fluorodeoxyuridine on E l l  (their stage 18) was specific for digital defects in both 
fo re- and hindpaws of E17 autopsied mice. The long bones of the forelimb were no 
longer affected  a t this stage  while homologous structu res in the hindlimb showed 
moderate e ffec ts  (61).
In the current study, skeletal defects  of the limbs were examined in detail. 
Examination of E17 fetuses a t autopsy and subsequent evaluation of the Alizarin 
red stained skeletons did not reveal any e ffec t of FU on development o f limb long 
bones a t  the low (10 mg/kg) or m oderate (20 mg/kg) doses. One fetus in the la tte r  
group was confirmed to display both fore- and hindlimb micromelia a t autopsy but 
was not similarly evaluated a fte r  staining with Alizarin red. Obviously this error 
is far from sta tis tic a l relevance and no a ttem pt is made to magnify its  importance, 
but it does allude to an important limitation of the experimental design. The 
experim ental outcome is dependent upon the ability  of the investigator to  make 
accura te  observations. What is reported  are  the observable d ifferences, not 
necessarily the actual differences. The power of the te s t is limited to  the power 
of human perception a t its  most disadvantaged application -  the indirect
79
80
comparison. Thus, a  serious question remains unanswered. Were e ffec ts  of 20 
mg/kg FU on the development of long bones not present or not detected?
Forelimbs trea ted  in utero and explanted for culture on E l l  or E12 
dem onstrated reduced long bone area a t  both 10 and 20 mg/kg. The heightened 
sensitivity of the in vitro tests  may be due to: (1) more precise definition of
actual d ifferences via the use of quantita tive  image analysis and/or (2) 
potentiation o f the e ffec t of FU by the culture procedure. It is highly probable 
tha t both factors are  responsible. In this experiment, subjective evaluation of 
cultured limbs would require discrimination of size changes of about 10%. 
Kwasigroch e t al. (70) reported th a t in vitro adm inistration of retinoic acid (0.25 
pg/ml) to  E l l  and E12 cultures of mouse forelimbs produce enhanced cartilage 
formation of about 10% as measured with computerized imaging. Without the use 
of a  sensitive quantitative system, these d ifferences may have been unnoticeable, 
since there were no observable abnormalities in the shape of the affected  limbs.
The idea th a t the culture technique po ten tia tes the drug e ffec ts  is 
supported in the observation of digital e ffec ts . Ectrodactyly in E17 fetuses was 
not expressed a t  10 mg/kg FU. Cultured limbs from fetuses exposed in utero to 
this dose exhibited g rea ter sensitivity; the incidence of phalangeal ED was well 
pronounced in both E12 and E l l  cultures. With few exceptions, the responses of 
cultured limbs were dose-dependent in phalanges and m etacarpals demonstrating 
that the observed e ffec ts  were treatm ent re la ted . An obvious pattern  of effect 
was discernable and, very importantly, was consistent with in vivo studies. Digit I 
was most affected  followed in decreasing order by digits V, II, IV and III. The 
patte rn  consistency suggests th a t the in vitro te s t  results a re  directly  related  to  
those observed in vivo. Similarly, preaxlal polydactyly was observed in the fore- 
(3%, 40 mg/kg) and hindlimbs (3%, 20 mg/kg) of E17 fetuses. Treatm ent with 10 
mg/kg was subteratogenic in vivo but when trea ted  forelimbs were cultured on E l2,
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polydactyly of digits I and II was produced (Figure 39). The expressivity of mutant 
digital duplications has been reported to  increase with adm inistration of normally 
sub-effective doses of FU (24,86).
The ability of the culture technique to po ten tia te  FU e ffec ts  has sound 
theore tical basis. Neubert e t al. (90) dem onstrated th a t when G il mouse limb buds 
were introduced to  culture, about 30-40% of the in itia l explant was lost (as 
measured by to ta l DNA and protein content) in the firs t 24 h. In the present 
study, culture of untreated  forelimbs resulted in a  33% decrease in DNA measured 
between Oh and 36h of culture. Thus, limb culture may essentially ac t as a  "co- 
teratogen" whose mechanism is cell death. E xp lanation  of the limb bud may also 
in te rfe re  with the normal processes for regulated growth and eliminates exposure 
of the limb to in u tero  repair mechanisms. This could account for the improved 
sta tu s of E l2 vs. E l l  cultured limbs with respect to ED.
Thus far this discussion has focused on results obtained following 
adm inistration of FU to  the pregnant mice. It was of in terest to see if FU would 
prove teratogenic and/or toxic if administered directly to developing limbs in v itro . 
Overwhelming evidence suggests th a t unless subject to metabolic activation, FU is 
in itse lf harmless to mammalian cells (83). If the presence of FU in vitro proved 
deleterious to the limb bud, two assumptions would be inevitable. F irst, the limb 
primordium is capable of metabolic activation  of the drug. Second, the observed 
defects resultant from in vivo exposure are probably due to  e ffec ts  in situ.
In this study, in v itro  adm inistration of FU was both teratogenic and toxic. 
ED of digital elem ents was dose-dependent and often  reached 190%. The pa tte rn  
of e ffec t was consistent with those seen in vivo and in vivo/in vitro. The severity 
of chronic in vitro exposure to  FU was also evident in the apparent general
i
toxicity seen in some hindlimbs cultured in the presence of 2.0 mg/ml and 0,2 
mg/ml. By the end o f the culture period, some of these explants were greatly
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reduced In size, were fragmented and fragile and were devoid o f any cartilage as 
determined by metachrom atic staining with Alcian blue. The rudiments th a t did 
form were reduced In size compared to  un treated  controls.
If the primary e ffec t of FU adm inistered in v itro  was via inhibition of 
thymidylate synthetase, concomitant addition of thymine to cultures containing FU 
should be beneficial in am eliorating the FU induced effects . Addition of thymine 
to untreated  forelimb cultures enhanced chondrification of limb elem ents distal to  
the humerus by either increasing the size of exisiting anlagen (long bones) or aiding 
the formation of previously missing elem ents (digits). In hindlimb cultures, the 
areas of all bone anlagen were enhanced except for the fibula. The incidence of 
ED increased however.
The ability of thymine to  dampen FU effec ts  was dose-related. ED was 
generally decreased a t  the highest thymine dose compared to limbs exposed only to 
0.02 mg/ml FU while, expectantly, lower doses were less effective. While 0.002 
mg/ml thymine was rarely effective in reversing FU e ffec ts , it  substantially 
enhanced ED of MC -  UI, IV and was associated with decreased area of the scapula 
and humerus. The explanation or significance of these observations remain a 
mystery.
Improved grow th/differentiation of bone anlagen with the addition of 
thymine suggests th a t inhibition of the c ritica l enzyme, thymidylate synthetase was 
involved in the genesis of FU-induced malformations. Thymine could be 
incorporated into DNA via the salvage pathway, thus bypassing the biochemical 
lesion imposed by FU. Also, thymine could a c t as a  com petitor for the salvage 
pathway enzymes and cofactors needed to  ac tiv a te  FU. The observation, however, 
th a t all param eters examined a f te r  co-adm inistration of even high doses of thymine 
were s till greatly  decreased compared to  un trea ted  controls, suggests tha t other
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mechanisms might be Involved in the teratogenesis. Incorporation of FU into RNA 
and possibly DNA. must be considered.
In the mechanistic sense, it  is crucial to  consider the ta rg e t tissue 
specificity  of the teratogen. Skalko (116) customized a  well-known pharmacologic 
principle (26) to  the science of teratology by sta ting  th a t te ra togen-target tissue 
reaction is dependent on the presence of agent-specific receptors in those cells. 
Thus, recognition of phenotypic sensitivity to  a  given agent may aid in 
determination of its mode of action. Kwasigroch and Neubert (68) showed th a t in 
u tero  treatm ent of mice with retinoic acid affected  chondrogenesis but not
myogenesis. Kwasigroch e t  al. (69) substantiated  those results la te r  using an in 
vivo/in vitro  approach. Limbs exposed in vivo to  retinoic acid were cultured and 
analyzed with optical image analysis. The ra tio  of so ft tissue to to ta l bone was 
increased in trea ted  limbs dem onstrating the chondrogenic specificity of the 
retinoic acid insult. Also, form factors of developing bone anlagen were affected  
in a dose-dependent fashion indicating a  specific e ffec t of retinoic acid on tha t 
tissue.
The same in vivo/in vitro approach was used in the present study to  portray 
the nature of FU-induced teratogenesis, FU did not consistently a ffec t shape 
facto rs of individual bones. No dose dependent e ffec ts  were produced, although 
occasional rounding (increase in shape fac to r with respect to control) was
observed. In this respect, FU is unlike retinoic acid which produced a consistent 
pa tte rn  of reduction in length when administered e ither in vivo (69) or in vitro  
(70). Soft tissue/bone ratios were not a ffec ted  in cultured limbs from fetuses 
trea ted  with FU in vivo. The changes in soft tissue/bone ra tio  seen in in vitro
trea ted  limbs result from high incidence of missing bone elements. Thus, the
e ffec t of FU was non-specific, affecting  chondrogenic and (pre-) myogenic tissues 
equally.
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The e ffec t of FU on in v itro  cartilage development was expressed in three 
distinct responses: overt toxicity  of the explant, failure to form limb components 
and reduction in the areas of bone anlagen present. The type of response that 
occurred in a  particular experiment was re la ted  to  intensity of exposure to the 
drug, the cranio-caudal sequence of development in the embryo, the proximo-distal 
sequence of development within the limb and the regulatory abilities of the  limb 
and/or a given bone anlagen.
In vivo exposure to  40 mg/kg FU was associated with failure to thrive in 
some hindlimb cultures. Limbs were deteriorated , fragile and contained no 
cartilage as determined by metachrom atic staining with alcian blue (Figure 40). 
Chronic in v itro  exposure to 0.2 or 2.0 mg/ml produced an even g rea ter number of 
such results. Toxicity was not observed a t  o ther doses or in forelimb cultures .
The e ffec t of FU on the formation and growth of cartilage rudiments was 
re la ted  to  the temporal pa tterns of limb develoment. Within the limb, proximal 
s truc tu res are formed firs t and d ifferentia tion  proceeds distally. In the 
experiments reported here, the  long bone/paw ratios o f cultured limbs were 
increased by FU indicating g rea ter sensitivity o f the paw to  treatm ent a t this time 
o f embryonic development. This temporal sensitivity o f the paw to  teratogenic 
insult has been reported previously (66). Also, all treatm ents a t all doses resulted 
in substantial ED. Absence of long bones was not as frequent.
In addition to  proximo-distal limb development, there  is a cranio-caudal 
progression of embryonic morphogenesis, such th a t the hindlimb bud appears about 
24h la te r than the forelimb. Thus, periods of peak susceptibility of homologous 
fore- and hindlimb components vary. Hindlimb evaluations in this experiment were 
usually similar to those for forelimbs but e ffec ts  were more severe. This finding 
agrees with previous studies using retinoic acid (66, 69). The incidence of ED/SD
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Figure 40. Some cultured hindlimbs from fetuses exposed in Jn u tero  to  
40 mg/kg FU displayed no m etachrom atic staining with 
Alcian blue. This was also observed in in v itro  trea ted  
hindlimbs (0.2 and 2.0 mg/ml FU).
8 6
87
was increased in hindlimb cultures. Absence of the femur, tibia, fibula and tarsals 
greatly  exceeded th a t of forelimb cartilages. Although d irec t comparisons cannot 
be made between the area measurements of fo re- and hindlimb bone anlagen, it 
seems paradoxical th a t forelimb long bones were affected  in both E l l  and E12 
cultures while those of hindlimbs were affected  only in E12 experiments. It has 
been previously proposed th a t a "critical mass" of determ ined cells is required for 
the formation of cartilage blastem a (ISO). When limbs are  introduced to  culture, 
there  is an initial period o f extensive cell death  followed by recovery within 24h 
(90). It is possible that the mean areas reported for untreated  hindlimb components 
cultured on E l l  represent the smallest possible rudiment th a t might be formed 
under these conditions. Subsequent growth of the cartilage model may not be 
possible since regulatory adjustments must be made during specific and fin ite  
periods. In tha t case, treatm ent with FU could not exert an influence on the 
rudiment size, but only on its  formation. This phenomenon was dem onstrated in the 
most sensitive hindlimb bone anlagen, the fibula. Of n = 49 fibulae per 
experim ental group, 49 were present in untreated  controls, 47 a t  10 mg/kg, 42 a t 
20 mg/kg and 32 a t 40 mg/kg. It should also be noted tha t in the la tte r  group, 
several litte rs  were found to  have no cartilage formation and were not used for 
image analysis. This represents a  necessary bias which is nevertheless an 
im portant outcome.
Hindlimb sensitivity may also be related to  regulated growth. The interval 
between the appearance of the limb bud and the d ifferentia tion  of the digits Is 
longer in fo re- than in hindlimbs (128). The former may therefore  have an overall 
g rea ter capacity  for regulation (61). Regulation may also explain the d ifferen tia l 
sensitivities of the components within a particu lar limb type. In addition to  the 
temporal pa tterns of growth described above, a second axis of growth is apparent
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post- (ulnar edge) to  pre-axial (radial edge). Thus the ulna (fibula) and digits IV 
and V form shortly before the radius (tibia) and digits III, II, L With regard to 
simply a  temporal scale of sensitivity, one would therefore  expect peak e ffec ts  in 
the ulna (fibula) and post-axial digits to  preceed the radius (tibia) and pre-axial
digits. The results of this experiment clearly  do not present this pattern . The
p a tte rn  of digital e ffec ts  was, in order of decreasing severity , digit I > V > II > 
>1V >111. Coincidentally, the fibula was much more sensitive than was the tibia. It 
Is suggested then that each limb component possesses a  unique capability to  adjust 
to developmental disturbances. D ifferential regulatory ability in the tibia—fibula 
(47) and phalanges (31) has been discussed.
Regulation is best regarded as more than a unimodal process. Production of 
a normal limb involves many events th a t have the potential to go awry. 
"Regulation" may thus refer to a  number of compensatory responses to alterations 
in normal developmental sequences. For example, if  development of a  normal 
cartilage rudiment requires the coalescence of a "critical mass" of specified cells, 
then the introduction of a  cytocidal agent a t an effective dose and time would 
challenge the normal developmental sequence by removing cells from the
condensation. If the rudiment can compensate by recruiting additional cells
surrounding the cen tral core or by extended mitotic activ ity  within the 
condensation, a normal rudiment may s till form.
At the time of treatm ent with FU, the forelimb is well advanced in its 
commitment to d ifferentiation though the cartilage primordia of the paw are not 
yet defined. The hindlimb, because of its temporal lag, shows less committment to 
phenotypic expression and is more engaged in proliferative growth. Therefore, in 
determined rudiments (forelimb longbones and perhaps the most proximal hindlimb 
elements) FU no longer governs whether the cartilage will be present or not, but
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affec ts  the size to which it will develop. In regions still heavily engaged in 
proliferation (forepaw and most of the hindlimb) the most noteable e ffec t of FU 
may be to prevent formation of a rudiment, perhaps by preventing the formation of 
a "critical mass" of determ ined cells. If regulation of cell loss was successful, a 
rudiment might be formed but may not necessarily have the ability to  grow 
normally.
If the bulk of forelimb cells have withdrawn from the proliferative pool and 
a re  engaged in differentiation (here the production of cartilage matrix) while 
hindlimb cells are dividing, then forelimbs should be more capable of regulatory 
compensation regarding differentiation, hindlimbs of proliferation. This 
in terpretation  is supported by the biochemical evaluations performed. Recovery of 
expected cell loss imposed during the initial culture period was essentially 
complete in untreated hindlimbs by 36h while forelimb DNA a t that hour was 
reduced by 33%. By 72h both fore* and hindlimbs appear to have compensated for 
initial losses. Even a f te r  treatm ent with 20 mg/kg, hindlimbs dem onstrated a 
g rea ter capacity to regulate for cell loss than did forelimbs. D ifferential limb-type 
responses when exposed to  FU in v itro  were not remarkable. However, hindlimbs 
cultured in these conditions often exhibited overt toxicity only rarely  seen in fore­
limb cultures. Therefore, the sim ilarity in DNA content a t 72h implies a  g rea te r 
compensatory response of hindlimbs.
Increased capacity  of hindlimbs for regulation of changes in cell number is 
supported by thymine rescue studies. Concom itant addition of thymine to FU in 
vitro trea ted  cultures appeared to  benefit hindlimbs more than forelimbs. In the 
la tte r , 0.2 or 0.02 mg/ml thymine added to  culture medium containing 0.02 mg/ml 
FU resulted in decreased ED. All areas of individual bone anlagen were increased 
a t  the highest thymine dose while a t  0.02 mg/ml thymine only the radius and
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carpals were improved. At the lowest dose of thymine, (0.002 mg/ml), a rea  values 
were unchanged or even decreased (scapula, humerus). In hindlimbs cultured in the 
presence of 0.02 mg/ml FU, simultaneous addition of any dose of thymine resulted 
in decreased ED. At the higher doses of thymine the values of MT-III, IV were 
improved to  the level of un treated  controls. These doses also improved the area of 
individual anlagen. At 0.002 mg/ml thymine + 0.02 mg/ml FU, a rea  of hindlimb 
bones were unchanged.
The ability of thymine to improve the sta tus of limbs trea ted  with FU in 
vitro may involve more than one mechanism. Inhibition of thymidylate synthetase 
by FU prevents the methylation of dUMP to form dTMP in de novo pyrimidine 
synthesis. Thymine can be cycled via the salvage pathway to  ultim ately provide 
dTTP for DNA replication, bypassing the FU-induced lesion. FU activation requires 
the same salvage pathway enzymes and co-substrates utilized in thymine recycling. 
Therefore, thymine may ac t as a  com petitive inhibitor a t the enzyme level and may 
effectively  decrease the pool of available deoxyribose required for FU activation.
While hindlimbs appeared more successful in regulating DNA content, 
forelimb cultures appeared more capable of regulating overall protein content as 
measured between 36h and 72h in untreated  (FL: +35% vs. HL: -15% change), in 
vivo (FLi -25% vs. HL: -44%) and in v itro  (FL: -57% vs. HL: -64%) cultures. 
Percent change for both limb types a t 0.2 mg/ml, in vitro were artificia lly  small 
due to especially large reductions during the in itial 36h of culture.
CHAPTER 5 
SUMMARY
In this study, the use of submerged limb culture in teratogenicity  testing was 
dem onstrated using a "model" teratogen, S-fluorouracil (FU). The major objectives 
of the experiments were to: (1) define the teratologic nature of FU in ICR mice 
autopsied on E17 following in u tero  exposure on E l l ,  (2) compare the effects  of FU 
on limb development as defined in vivo to  studies In vitro , (3) determine whether 
FU administered fn vitro  to  untreated  limbs is capable of altering normal limb 
morphogenesis, (4) examine whether co-administration o f thymine is capable of 
modulating e ffec ts  of FU as defined in the in vitro studies, (5) monitor biochemical 
param eters of growth and development (to tal DNA and protein content) in cultured 
limbs trea ted  in vivo or in v itro , (6) examine the nature of FU-induced limb defects 
using information obtained from quantitative image analysis with regard to  the 
ta rg e t tissue(s) a ffec ted , and (7) identify the normal processes of limb development 
as they re la te  to FU teratogenicity .
In vivo exposure to FU on day eleven of gestation (E ll)  resulted in 
dose-dependent expressions of ectrodactyly  (ED) and syndactyly (SD) and decreased 
values for Alizarin red stained limbs of E17 fetuses. E ffects of FU observed with 
in vivo/in vitro  and in vitro studies largely resembled each o ther and those seen in 
vivo. A consistent pa ttern  of e ffec t was observed and responses were 
dose-dependent. The e ffec ts  of FU were increased when in u tero  trea ted  limbs 
were placed in culture. This heightened sensitivity in v itro  may assist in 
recognizing xenobiotics with subthreshold or marginal expression in vivo. G reatest 
sensitivity  resulted when limbs were chronically exposed to the drug in vitro. The 
occurrence of dose-dependent responses in vitro implies th a t the explanted limb 
bud is capable of anabolism of FU into one or more of its active 
m etabolites.
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The addition of thymine to cultures containing 0.02 mg/ml FU resulted in 
dose-dependent improvement of growth and differentiation and decreased incidence 
of digital e ffec ts . G reatest improvement was observed in hindlimb cultures. 
Similarly, hindlimbs were more capable than forelimbs in regulating cell loss as 
determined by to ta l DNA content a t 0, 36 and 72h of culture. Conversely, 
forelimbs showed g rea ter recovery of to ta l protein content.
In general, the e ffec ts  of FU were non-specific. Soft tissue and developing 
cartilage were similarly a ffec ted  and the shape factors of developing anlagen were 
not consistently changed.
In addition to  regulation, o ther fea tu res of normal morphogenesis were 
observed in culture studies. The proximo-distal sequence of limb development and 
the cranio-caudal axis of embryonic growth were obvious. In a ll studies, long 
bone/paw ratios were increased due to  the predominate e ffec t of FU on paw 
structures. Also, hindlimbs were more affected  than forelimbs.
Submerged limb culture provides a  useful model for the examination of 
xenobiotic e ffec ts  on limb development and allows some com parative evaluation 
among in vivo, in vivo/ln v itro  and in v itro  studies. The ability  to  monitor growth 
and development via specific quantita tive  methods (i.e ., image analysis) is an 
important improvement over s tr ic t in vivo protocols which rely heavily on 
error-prone subjective evaluations.
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APPENDIX A
t
To p repare  FU (Lot 328058, Hoffmann -  La Roche, In c .)  fo r  In je c tio n , 
100 mg was added to  50 ml o f d i s t i l l e d  w ater (s to c k  -  2 mg/ml FU). This 
s o lu tio n  was mixed v ia  m agnetic s t i r r e r  and f i l t e r  s t e r i l i z e d  (M illip o re  
f i l t e r ,  0 .45 pm) in to  s t e r i l e  b o t t l e s .  Pregnant mice were weighed to  the  
n e a re s t O .lg  and in je c te d  accord ing  to  the  form ula:
Body weight (kg) » dose (mg/kg) „  ral of st<Jck injeoted
2 mg/ml
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APPENDIX B
Whole fe tu s e s  (E17) were p rocessed  fo r exam ination o f s k e le ta l  d e fe c ts  as 
fo llow s:
1 . Fixed 95% EtOH 3 di
2 . C leared 1% KOH 36 h
3. S ta in ed A liz a r in  Red* 24 h
4. Rinsed 1% KOH 1 h
5. S to red G ly c e r in /100% EtOH (1 :1 ) 1 h
•A liz a r in  Red was d is so lv e d  in  85% EtOH. T his s o lu tio n  was added 
dropw ise to  100 ml o f 1% HDH u n t i l  the  c o lo r  was deep wine red .
S k e le ta l components of in d iv id u a l fe tu se s  were c r i t i c a l l y  examined 
fo r changes in s iz e ,  shape and /o r s ta in in g  p o te n t ia l .  Each bone was 
a ssigned  a  su b je c tiv e  r a t in g  between 0 ( t o t a l l y  m issing ) and f iv e  (normal 
ap p earan ce). S p e c if ic  r a t in g  c r i t e r i a  fo r  each bone is  o u tl in e d  below.
(con tinued)
APPENDIX B (con tinued) 
Organ or
Region 0 1 2 3 4 5
S ku ll ABSENT Exencephalic /  
bones m issing
Large fo n ta n e lle s  
and su tu re s
s l ig h t  enlargem ent 
in fo n ta n e lle s  and 
s u tu re s /s h o r t  snout
obvious 
reduction  
in s ta in in g
Normal
Jaw Loss of 
m andible 
+ red  in 
m ax illa
severe  c l e f t  in 
max. and mand.
+ m icrognath ia
m ild  c l e f t  w ith  
m icrognath ia
m icrognath ia  
o r c l e f t  max. o r 
m andible
obvious 
reduc tion  
in  s ta in in g
Normal
Sternum ABSENT severe  reduction  
in  p a r t s / s i z e
some red u c tio n  
in p a r t s / s i z e
sm all obvious 
red u c tio n  
in  s ta in in g
Normal
Ribs ABSENT many misshapen & 
m issing
some m isshapen 
or some m issing
wavy or nodular obvious 
reduct ion 
in  s ta in in g
Normal
V erteb rae ABSENT severe  reduction  
in  numbers
severe  cu rv a tu re  
w ith  fused v e r t ,  
and /o r sp in a  
b i f id a
c u rv a tu re , fused 
v e rte b ra e  o r sp ina  
b i f id a
obvious 
red u c tio n  
in s ta in in g
Normal
Forelim b/ 
Hindlimb
ABSENT m issing  bones severe  red u c tio n  
in s iz e  o f bone(s)
spontaneous f ra c ­
tu re  o r s l ig h t  
red u c tio n  in  bone 
s iz e
obvious 
reduc tion  
in s ta in in g
Normal
Long
Bones
ABSENT Nodule severe  red u c tio n  
in  len g th
s l ig h t  reduc tion  
in len g th  and/or 
p rocess or 
spontaneous f r a c t .
obvious 
reduction  
in  s ta in in g  
s l ig h t  bend
Normal
Forepaw/
Hindpaw
ABSENT most m etacarpals 
and a l l  phalanges 
m issing
phalanges and 
some MB's 
m issing
phalanges m issing obvious 
red u c tio n  
in s ta in in g
Normal
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APPENDIX C
Commercially p repared  B ig g e r 's  medium* (BGJb, Gibco L ab o ra to rie s )  was 
supplem ented (3 :1 ) w ith  a  s a l t  so lu tio n  (700 mg NaCl, 42 mg HC1 and 67 mg 
CaC^g pet* 100 ml d i s t i l l e d  w a ter) to  p rov ide  a  f in a l  c u l tu re  medium w ith  
an o sm o la rity  o f  about 335-340 nOsm. To enhance co n d itio n s  fo r 
chondrogenesis, a sc o rb ic  a c id  was added to  th e  medium a t  a  f in a l  
c o n c e n tra tio n  o f 0.85 uM. To prophylax a g a in s t s e p s is ,  g en tim ic in  s u l f a te  
was provided  a t  50 pg/m l. T his am inoglycoside has broad spectrum  gram 
n eg a tiv e  b a c te r ic id a l  p ro p e r t ie s ,  p robably  r e s u l t in g  from s p e c if ic  b ind ing  
o f the drug to  the  30S ribosom al s u b u n it, thus in te r f e r in g  w ith  p ro te in  
s y n th e s is  (4 3 ).
P repared  medium was sea le d  in a 50 ml Wheaton b o t t l e  and a e ra te d  fo r  
two m inutes w ith  a gas m ix tu re  o f 50% 0g, 5% OOg and 45% Ng.
•The com position o f B ig g e r 's  medium is  ( 8 ) :
Component mg/L
INORGANIC SALTS
MgSO, . 7H„0 
KC1 *
200.00
530.00
kh2po4
NafiOCE
160.00
3,500.00
NaCl * 8 , 000.00
OTHER COMPONENTS
Calcium  la c ta te 555.00
G lucose 5 ,000.00
Phenol red 20.00
(con tinued)
APPENDIX C (con tinued )
AMINO ACIDS
L-A rginine HC1 75.00
L -C yste ine  HCl'HgO 90.00
L-G lut amine 200.00
L -H is tid in e  HC1* 'H^O 150.00
L -Iso leu c in e 30.00
L-Leucine 50.00
L-Lysine HC1 240.00
L-M ethionine 50.00
L -P heny lalan ine 50.00
L-Threonine 75.00
L-Tryptophan 40.00
L-T yroslne 40.00
L -V aline 65.00
VITAMINS
Alpha tocopherol phosphate 1.00
B io tin 0 .20
Calcium  p an to th en a te 0 .20
C holine  c h lo rid e 50.00
F o lic  a c id 0.20
Inosi to l 0 .20
N icotinam ide 20.00
Para aminobenzoic ac id 2 .00
P yridoxal phosphate 0.20
R ib o flav in 0.20
Thiamine h y d roch lo ride 4.00
Vitamin 0.04
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APPENDIX D
Hanks' balanced  s a l t  so lu tio n  was purchased from Flow L a b o ra to r ie s , 
I n c . ,  (R o ck v ille , M aryland). The c o n te n ts  o f each pre-m easured package 
a re  l i s t e d  below. One package was d is so lv e d  w ith  g e n tle  s t i r r i n g  in room 
tem p eratu re , d i s t i l l e d  w a ter. NaHOO  ^ was added (Q.35g/L) and the  pH was 
a d ju s te d  to  7 .2  u sing  IN NaOH o r IN HCl. T his so lu tio n  was r e f r ig e ra te d  
u n t i l  u se .
The’ com position o f Hanks' balanced s a l t  powder is  (48 ):
Component mg/L
INORGANIC SALTS
CaCl 140.0
KC1 1 400.0
KH„PO. 60.0
Mg2o4 97.7
NaCl 8000.0
Na2HF04 47.5
OTHER COMPONENTS
D extrose 
Phenol Red, Na
1000.0
17.0
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APPENDIX E
Limbs removed from c u l tu re  were p rocessed  acco rd in g  t  
p ro to c o l:
1. Fixed
2. D ecolorized
B ou in 's  f ix a t iv e :  
P ic r ic  ac id  
40% form alin  
g la c ia l  a c e t ic  
a c id
NH,OH/70% EtOH
(50 drops/1  i t e r )
750 ml 
250 ml 
50 ml
3. R insed
4. S ta in ed
5. C leared
6 . Dehydrated
70% EtOH
A lcian  b lu e :
95% EtOH 750 ml
g la c ia l  a c e t ic  250 ml
ac id
a lc ia n  b lu e  75 mg
95% E tO H /glacial a c e t ic  a c id  
(75ml/25ml)
EtOH s e r ie s :
80%
80%
95%
A bsolute
A bsolute
7 . C leared Xylene
the  fo llow ing
overn igh t
2 changes: 
lh  and 
o v ern ig h t
2 changes: 
lh  each
overn igh t
overn igh t 
lh  each
8 . S to red Cedarwood o i l
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APPENDIX F
C u ltu red  limbs to  be used fo r biochem ical assays were r in se d  and 
s to re d  in  0 . 2M phosphate b u ffe r :
19.0 ml S o lu tio n  A
81.0  ml S o lu tio n  B
100 ml d i s t i l l e d  w ater
S o lu tio n  A:
S o lu tio n  B:
Sodium phosphate monobasic 
(NaH2P04 )
d i s t i l l e d  w ater
Sodium phosphate d ib a s ic  
(Na2HF04 *7H20)
d i s t i l l e d  w ater
27.80 g 
to  1000 ml
28.39 g 
to  1000 ml
115
APPENDIX G
The e f f e c t iv e  co n cen tra tio n  o f the  DNA stan d a rd  s to ck  so lu tio n  
(Salmon sperm DNA = 420 pg/m l) was determ ined by m easuring the  absorbance 
o f a  1:19 d ilu e n t (s to c k : 10 nM TRIS b u f f e r ) .  P ro te in  s tan d a rd  stock  
so lu tio n  (bovine serum albumin = 1 mg/ml) was s im ila r ly  measured as a 1:1 
d ilu e n t (s to c k : 10 nM IRIS b u f f e r ) .  E f fe c tiv e  co n ce n tra tio n s  were 
determ ined:
*
DNA c o n ce n tra tio n  -  002go x 1 , -  21.7 OD260
Edna "e/ 1" 1
P ro te in  c o n ce n tra tio n  = OD2g0 x 1 , ^ r o t  ”  1 ^SOO
_ 5 5 7 S I
DNA
^  (nm) Absorbance
240 0.247
260 0.457
260/240 1.85
P ro te in
(nm) Absorbance
260 0.268
280 0.482
280/260 1.80
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APPENDIX H
Diphenylamine (DPA, Lot F8A, Eastman Kodak C o .) reagen t was p repared  
inm edia te ly  p r io r  to  u se . DPA (3 .0 g ) was d isso lv e d  w ith  s t i r r i n g  in 30 
ml o f g la c ia l  a c e t ic  a c id . C oncen tra ted  s u l f u r ic  a c id  (2 .75  m l) was 
added and th e  to ta l  volume was then in c reased  to  100 ml w ith  a c e t ic  a c id . 
A cetaldehyde was d i lu te d  in ic e  co ld  d i s t i l l e d  w ater (1 :4 9 ) and 0 .5 ml of 
the  d ilu e n t was added to  the DPA s o lu tio n .
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